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Murine embryonic stem cells (ESCs) are self-renewing, pluripotent cells able to 
differentiate into cells of all three germ layers. Pluripotency and self-renewal are 
maintained primarily by the core transcriptional factors Nanog, Oct4 and Sox2, but 
require the cooperation of other factors and coregulators and an efficient telomere 
maintenance mechanism. In mammals, telomere maintenance is achieved via a 
telomerase reverse transcriptase (Tert) that acts together with an RNA component 
(Terc). Maintenance of functional telomeres is essential to allow ESC proliferation, 
nevertheless if and how it is involved in the achievement and preservation of cell 
differentiation is still unknown. Here, we used Tert deficient mouse ESCs to 
elucidate the role of telomere length in differentiation.  We found that Tert-/- ESCs 
with critically short telomeres are delayed, but still capable, to achieve differentiation 
after leukemia inhibitory factor (LIF) withdrawal and all-trans retinoic acid (ATRA) 
treatment, but failed to maintain it after LIF re-introduction to the growth medium. 
Telomere shortening effect on differentiation was accompanied by pluripotency gene 
dysregulation (e.g. Nanog overexpression), DNA hypomethylation and epigenetic 
disorders. This phenotype of metastable differentiation could be rescued by telomere 
lengthening via re-introduction of Tert, depletion of Nanog via short hairpin RNA, or 
via enforced expression of the de novo DNA methyltransferase 3b. These results 
reveal an unanticipated role of telomeres in the epigenetic regulation of gene 
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1.1 Embryonic stem cells  
Stem cells are characterized by two major traits: A) They are able to extensively, in 
some case unlimitedly, self-renew without entering senescence, B) they also possess 
the ability, called potency, to differentiate into one or more cell types (Hirai et al., 
2011; Nichols and Smith, 2009). In mouse, an arbitrary distinction of the different 
kinds of stem cells can be performed according to the extent of their potency. In this 
hierarchical model the totipotent stem cells, cells from the early morula, occupy the 
top position. Zygote undergoes a cleavage division stage that, eventually, leads to the 
formation of the morula, which is formed by 8-16 cells called blastomeres. 
Blastomeres ultimately compact together, and the outside cells begin to form the 
trophoblast. Until compaction, blastomeres are symmetric (each cell has the same 
features and potency of the others), unresponsive to extrinsic signals, and able to 
differentiate into any kind of both embryonic and extra-embryonic cell (Hillman et 
al., 1972; Nichols and Smith, 2009; Selwood and Johnson, 2006).  
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Pluripotent, or embryonic, stem cells (ESC) arise soon after totipotent ones in terms 
of potency. Compacted blastomeres give raise to a structure called a blastocyst, 
formed by the trophoblast and the inner cell mass (ICM). ICM produces both 
embryonic (epiblast) and extra-embryonic (hypoblast) lineages. ESCs are derived 
from the epiblast of the inner cell mass of pre-implanted blastocysts (Fig1) (Friel et 
al., 2005; Nichols and Smith, 2009; Nichols et al., 1998). They are able to give raise 
to any embryonic (but not extra-embryonic) cell and to form teratomas. In addition, a 
single pre-implantation epiblast cell, when injected into another blastocyst, can 
contribute to all cell lineages. Epigenetically, female ESCs are characterized by 
reactivation of the paternal X chromosome resulting in two active X chromosomes 
(Friel et al., 2005; Gardner and Beddington, 1988; Nichols and Smith, 2009).  
Epiblast stem cells (EpiSCs), derived from post-implantation epiblast, share many 
features with ESCs, like expression of key pluripotency genes, the ability to form, in 
vitro, cells from the three germ layers, and to form teratomas. However, EpiSCs are 
incapable to contribute to chimerism when injected into blastocysts, and female cells 
show random inactivation of one of the two X chromosomes (Heard, 2004; Mak et 
al., 2004; Nichols and Smith, 2009).  
Multipotent, or adult, stem cells are able to differentiate only into cells of a specific 
organ or tissue or system. They locate into different tissues in the adult organism and 
their role is to replace mature cells after damage or disease-induced stress (Friel et 




Figure 1. Schematic representation of early mouse embryo development. Zygote undergoes 
multi cell division to origin the morula, which compacts and gives raise to the early blastocyst 
(bottom left). Blastocyst is formed by the trophoblast (in red), which will generate extra-
embryonic tissues (e. g. placenta), a fluid-filled space called blastocoel, and the ICM. In the late 
blastocyst, the ICM is re-organized into epiblast (in blue), which will differentiate into the three 
embryonic germ layers: endoderm, mesoderm and ectoderm, and hypoblast (in green), which 
lies beneath the epiblast and generates extra-embryonic primitive endoderm tissues (e.g. yolk 
sac). ESCs are derived form the epiblast of pre-implantation blastocyst. Figure adapted from 
(Nichols and Smith, 2009). 
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The origin of ESC studies in culture can be traced to findings from the 1950’s on 
teratomas, a particular kind of tumour containing cells from the three germ layers: 
endoderm, mesoderm and ectoderm, and undifferentiated cells called embryonic 
carcinoma (EC) cells. EC cells, grown on mitotically inactivated fibroblasts, could be 
expanded in culture for years and were capable of multi-lineage differentiation 
(Martin and Evans, 1975). EC cells usage for pluripotency studies was severely 
limited by their tumour-related genetic instability, however they built the basis for 
future pluripotency studies (Friel et al., 2005; Martin, 1980).  
Murine embryonic stem cells from the ICM were first isolated in 1981 by Evans and 
Kaufman in Cambridge, and Gail Martin at University of California, San Francisco. 
ESCs cultured either on feeder cells (typically irradiated mouse embryonic 
fibroblasts) or on gelatin-coated dishes can be kept in culture for many passages and 
still maintain the ability to contribute to chimerism after blastocyst injection (Evans 
and Kaufman, 1981; Hirai et al., 2011; Martin, 1981). 
 
1.2 Pluripotency and self-renewal master regulators  
The ability to differentiate into cells of the three germ layers and to replicate without 
entering senescence are the key characteristics of ESCs both in the embryo and in 
vitro.  Pluripotency and self-renewal are mainly maintained by the core transcription 
factors Nanog, Oct4 and Sox2 (Chambers et al., 2003; Nichols and Smith, 2009; 
Nichols et al., 1998; Yuan et al., 1995). Their targets encompass both transcribed and 
inactive genes, some of which are involved in the maintenance of ESC self-renewal 
and pluripotency, whereas others execute critical developmental activities including 
differentiation into cells of the three germ layers (Loh et al., 2006; Niwa, 2007; Silva 
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and Smith, 2008). It is worth noting that many of the genes involved in the 
maintenance of ESC self-renewal and pluripotency are co-occupied by at least two of 
the core transcription factors, including the Sox2, Oct4, and Nanog promoter 
themselves (Ivanova et al., 2006; Li, 2010; Silva and Smith, 2008; Tsumura et al., 
2006).  
Oct4, encoded by the Pou5f1 gene, is a transcription factor that binds to the 
octameric sequence: ATGCAAAT. During mouse embryo development, Oct4 is 
expressed at the four-cell stage, and is subsequently restricted to the cells of the ICM 
of the blastocyst (Yeom et al., 1996). Oct4 expression has to be tightly regulated; as 
it has been shown that depletion of this factor leads to trophectoderm lineage, 
whereas its increase over two-fold leads toward endoderm and mesoderm 
differentiation (Niwa et al., 2000). However, it has been reported recently that 
heterozygosity for Oct4, and subsequent reduced expression, leads to a strong 
maintenance of pluripotent undifferentiated state. Oct4+/− ESCs present an 
enrichment of Oct4 and Nanog at pluripotency-associated enhancers, a more uniform 
expression of pluripotency factors, and a delayed differentiation compared to Oct4+/+ 
ESCs (Karwacki-Neisius et al., 2013).  
Sox2 has been identified as target of Oct4 and, just like Oct4, it is expressed in all 
the cells at the four-cell stage whereas it is restricted to the ICM in the blastocyst 
(Avilion et al., 2003; Grinnell et al., 2007). Sox2 is able to form a complex with Oct4 
to induce transcription of pluripotency genes, and both its depletion and its increase 
over two-fold lead to differentiation (Kopp et al., 2008; Nakatake et al., 2006; Rodda 
et al., 2005). 
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Nanog is the third component of the core pluripotency factors. During mouse 
development, it first appears in the morula, whereas its expression in the blastocyst is 
limited to the epiblast cells of the ICM (Chambers et al., 2007; Silva et al., 2009). 
Differently from Oct4 and Sox2, Nanog has a negative feedback on its own 
transcription, and its overexpression does not result in cell differentiation, but 
maintains cells in an undifferentiated state (Chambers et al., 2007; Fidalgo et al., 
2011). In addition, although Nanog is dispensable in the maintenance of 
pluripotency, it is crucial to acquire it both during embryogenesis and during 
reprogramming. In fact, Nanog-/- zygotes are unable to form epiblasts, and Nanog 
presence is fundamental to generate truly pluripotent induce pluripotent stem (iPS) 
cells, despite the fact that Nanog is unnecessary for the onset of reprogramming, as it 
is not one of the original Yamanaka factors (Oct4, Sox2, c-Myc and Klf4). 
Furthermore, forced expression of Nanog alone is able to convert EpiSCs into ESCs. 
(Chambers et al., 2007; Fidalgo et al., 2011; Li, 2010; Silva et al., 2009; Takahashi 
and Yamanaka, 2006). 
Although these three core factors locate are at the nexus of the pluripotency 
regulatory network and reciprocally influence their expression, in order to maintain 
pluripotency and self-renewal capacity they still need the collaboration of other 
factors and coregulators (Heng et al., 2010; Li, 2010). Factors like: Essrb, Klf2, Klf4, 
Tbx3, Tcf3, Sal4, Rex1, Zfp281 and many others have all been shown to regulate 
and/or be-regulated by the three core factors (Festuccia et al., 2012; Fidalgo et al., 
2011; Ivanova et al., 2006; Li, 2010; Navarro et al., 2012).  However, although each 
of the described factors is important to maintain an undifferentiated state, none, apart 
 7 
from Sox2 and Oct4, not even Nanog, is essential provided that the other 
pluripotency factors are present and functional (Martello et al., 2012)(Fig. 2).  
 
Figure 2: Schematic representation of pluripotency regulatory circuit. Oct4 and Sox2, which 
presence is essential for maintaining pluripotency and self-renewal, form the core of the circuit. 
Adapted from (Fidalgo et al., 2011; Martello et al., 2012). 
  
1.3 Signalling pathways in pluripotency maintenance  
There are many different pathways involved in the regulation and maintenance of 
pluripotency and self-renewal in embryonic stem cells. One of the main pathways 
involved in the regulation of pluripotency is the Wnt/β-catenin signalling network 
(MacDonald et al., 2009). This network is also targeted, by inhibition of GSK3-β, via 
the 2-inhibitors (2i) method (together with the inhibition of FGF4-MAPK) for ESC 
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maintenance (Blair et al., 2011). β-catenin has a pivotal role in the canonical Wnt 
signalling network, where its stability is controlled by a protein complex composed 
of adenomatous polyposis coli (APC), casein kinase 1 (CK1), Axin, and glycogen 
synthase kinase-3β (GSK3-β). In absence of binding between Wnt and its receptors, 
β-catenin is bound by APC and Axin and phosphorylated by CK1 and GSK3-β. 
Phosphorylated β-catenin recruits E3 ubiquitin ligase, which targets β-catenin for 
proteosomal degradation. The binding of Wnt to its receptors causes a 
phosphorylation-mediated GSK3-β inhibition with subsequent release of β-catenin, 
which migrates into the nucleus where it interacts with the Tcf3/Lef complex, and 
suppresses its transcription repression activity (Fig. 3) (Atcha et al., 2007; Sansom et 




Figure 3. Role of the Wnt canonical signalling network in ESC pluripotency and self-renewal. 
Wnt interaction with its receptors causes phosphorylation and subsequent inhibition of GSK3-
β , which in turn causes nuclear accumulation of β -catenin. In the nucleolus, β -catenin 
replaces histone de-acetylase 1 (HDAC1) in the Tcf3/Lef complex, suppressing its negative 
transcriptional regulation of Wnt responsive genes. Adapted from (Atcha et al., 2007; Blair et 
al., 2011; Martello et al., 2012). 
 
Independently of (or in combination with) the 2i method, it is possible to maintain 
mouse ESCs in a pluripotent and self-renewing state in culture by addition of the 
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cytokine LIF (leukemia inhibitory factor) to the culture media (Tomida et al., 1984). 
LIF belongs to the interleukin-6 cytokine family and, when it interacts with its 
receptor (LIFR), LIF acts on the maintenance of self-renewal and pluripotency 
through, at least, two signalling pathways: LIF/JAK/STAT3 and LIF/PI3K/AKT 
(Hirai et al., 2011; Tomida et al., 1984). 
The LIF/JAK/STAT3 signalling pathway is triggered by the binding of LIF to its 
receptor, and consequent dimerization of LIFR and gp130. This dimerization leads to 
activation of Janus kinases (JAKs) and subsequent recruitment of STAT3 to the 
receptor complex and its phosphorylation by JAKs. Phosphorylated STAT3 
dimerizes and migrates into the nucleus where it activates transcription of target 
genes (e.g. Klf4) (Fig. 4) (Hirai et al., 2011; Li, 2010; Martello et al., 2012; Matsuda 
et al., 1999; Nishinakamura et al., 1999).  
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Figure 4. The role of LIF/JAK/STAT3 in ESC pluripotency and self-renewal. LIF interaction 
with its receptors leads to hetero-dimerization of LIFR and gp130, with consequent JAK auto-
phosphorylation and STAT3 recruitment and phosphorylation. Phosphorylated STAT3 
dimerizes and migrates into the nucleus where it activates target gene transcription. Adapted 
from (Hirai et al., 2011; Martello et al., 2012). 
 
In the LIF/PI3K/AKT cascade, JAKs phosphorylate PI3K, which, in turn, activates 
AKT (Migone et al., 1998). There are numerous downstream targets of AKT, which 
positively regulates factors involved in maintenance of self-renewal and pluripotency 
(e.g. Tbx3, mTOR), and inhibits pro-differentiation agents like GSK3-β, that is able 
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to repress pluripotency genes also independently by restraining β –catenin activity 
(Fig. 5) (Hirai et al., 2011; Niwa et al., 2009).  
Although both LIF/PI3K/AKT and the canonical Wnt signalling networks target 
GSK3-β, these two networks can act independently of each other. In fact, it has been 
shown that even high-dosage treatment of mouse ESCs with LIF, as well as forced 
AKT activation, are incapable of altering β-catenin phosphorylation and nuclear 
levels (Paling et al., 2004; Watanabe et al., 2006). 
 
Figure 5. Role of LIF/PIK3/AKT pathway in ESC pluripotency and self-renewal. LIF 
interaction with its receptors causes JAK-dependent PIK3 phosphorylation. Phosphorylated 
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PIK3 phosphorylates and activates AKT, which can modulate many positive and negative 
pluripotency regulators (e.g. Tbx3). Adapted from (Hirai et al., 2011; Martello et al., 2012). 
 
However, LIF alone is incapable to maintain cells in a fully pluripotent state. ES 
cells also require the activation of inhibitor of differentiation (ID) genes. ID proteins 
are negative regulators of basic helix loop helix (bHLH) transcriptional factors, 
which comprise many pro-differentiation factors (e.g. MyoD, Neurogenin 1, etc.) 
(Benezra et al., 1990; Ying et al., 2003). In foetal calf serum (FCS)-supplemented 
growth medium, ID genes are activated by multiple pathways (e.g. fibronectin-
mediated integrin activation). In serum-free medium, transcription of ID genes can 
be stimulated by bone morphogenic protein 4 (BMP4). BMP4 binding to its 
receptors, which are heterodimers of serine/threonine kinases, leads to recruitment 
and phosphorylation of Smad1, 5 and 8 proteins. Phosphorylated Smads can 
dimerize with Smad4 and migrate into the nucleus where they induce the 
transcription of target genes (e.g. ID genes) and consequent inhibition of bHLH 
factors (Fig. 6) (Ying et al., 2003). 
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Figure 6. Schematic representation of Smad-mediated BMP4 inhibition of differentiation. 
BMP4 binds to its serine-threonine kinase receptors on the cell membrane. This ligand-receptor 
interaction causes recruitment of Smad1, 5 and 8 proteins to the receptor complex and 
subsequent phosphorylation. Phosphorylated Smads dimerize with Smad4 and migrate into the 
nucleus where they mediate certain transcriptional gene targets, such as ID genes. ID proteins 
bind to bHLH transcriptional factors, which are involved in differentiation processes (e.g. 
neural differentiation), thus preventing their binding to DNA.  Adapted from (Ying et al., 2003). 
 
In order to be defined as pluripotent, ESCs need to be able to respond to 
differentiation signals. In fact, the pluripotency factors Oct4 and Sox2 not only act to 
maintain ESCs self-renewal, but they also induce the transcription of fibroblast 
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growth factor 4 (FGF4), which renders ESCs responsive to differentiation cues 
(Kunath et al., 2007; Silva and Smith, 2008). FGF4 is a secreted factor and, when it 
binds to its tyrosine kinase receptors, it induces receptor trans-phosphorylation with 
subsequent activation of the mitogen-activated protein kinase (MAPK) signalling 
cascade through the MEK-Erk1/2 pathway. Once activated by phosphorylation, 
Erk1/2 can activate downstream transcriptional factors, which ultimately render the 
cells susceptible to lineage commitment stimuli (Fig. 7) (Kunath et al., 2007). 
 
Figure 7. Schematic representation of the FGF4 signaling network. FGF4 binds to its tyrosine 
kinase receptors (TKR) on the cell membrane. This ligand-receptor interaction causes receptor 
activation by trans-phosphorylation. Activated TKRs cause phosphorylation and subsequent 
activation of MEK, which in turn leads to phosphorylation of Erk1/2 and Erk1/2 downstream 
target transcriptional factors (TF).  Activated TFs migrate into the nucleus where they mediate 
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the transcription of target genes involved in response to differentiation clues. Adapted from 
(Kunath et al., 2007).  
 
1.4 Induced pluripotent stem cells 
Stem cell research, and above all human embryonic stem cell research, has been the 
center of deep public debate. Ethical issues were raised about the generation and use 
of human embryonic material for research. In 2006 Kazutoshi Takahashi and Shinya 
Yamanaka offered a potential solution to this debate. They found that differentiated 
cells could be reprogrammed to become embryonic stem cells by the introduction of 
four factors: Oct4, c-Myc, Sox2 and Klf4. These induced pluripotent stem (iPS) cells 
exhibited the self-renewal potential and morphology of ESCs, reactivated the 
silenced X-chromosome, and expressed ESC marker genes (Takahashi and 
Yamanaka, 2006). In addition, subcutaneous transplantation of iPS cells into nude 
mice resulted in the formation of teratomas. Furthermore, iPS cells that were injected 
into blastocysts contributed to mouse embryonic development (Takahashi and 
Yamanaka, 2006).  
It has become evident that reprogramming cannot happen without massive chromatin 
reorganization. In fact, already early in reprogramming, during the first 72h post 
transfection, there is a widespread histone modification activity. Changes in DNA 
methylation happen, instead, in later stages during de-differentiation (Fig. 8) (Koche 




Figure 8. Schematic representation of iPS cell reprogramming mediated by the four Yamanaka 
factors. Differentiated cells infected with retroviral vectors encoding Oct4, Sox2, Klf4 and c-
Myc exhibit, soon after infection, widespread histone modifications. Later on during the 
reprogramming process, genes involved in pluripotency (but not silenced by DNA methylation) 
are reactivated. DNA demethylation of pluripotency promoter genes happens only in late stages 
of reprogramming. Figure adapted from (Koche et al., 2011; Mikkelsen et al., 2008). 
 
1.5 Chromatin and epigenetic modifications 
Chromatin condensation is regulated by DNA methylation and by a wide range of 
histone post-transcriptional modifications. In mammals, DNA methylation at 
cytosine residues tends to essentially occur at CpG sites (Ramsahoye et al., 2000; 
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Ziller et al., 2011).  In the genome, CpG can cluster into so-called CpG islands, 
which are regions of DNA, approximately 1000 bp long, characterised by elevated 
CpG composition and usually unmethylated (Bird et al., 1985; Cross et al., 1994; 
Deaton and Bird, 2011). Approximately 70% of annotated gene promoters are 
associated with CpG islands, which usually define transcriptional permissive 
promoters (Deaton and Bird, 2011; Saxonov et al., 2006).  
CpG methylation at CpG island promoters acts to silence gene expression by 
recruiting chromatin-condensing factors and by direct, methylated-DNA based, 
transcription factors binding inhibition (Klose and Bird, 2006). CpG promoters can 
also be silenced by histone modifications mediated by Polycomb complex proteins 
(see section 1.6). 
Among histone modifications, acetylation was the first to be identified (Phillips, 
1963). Acetylation neutralises histone positive charges (due to lysine residues, where 
acetylation occurs) weakening the opposite charge attraction between histone and 
nucleosomal DNA, and leading to a more relaxed chromatin state that is accessible to 
transcriptional factors (Zentner and Henikoff, 2013). Lysine acetylation and 
deacetylation processes are mediated by histone acetyl transferases (HATs) and 
histone deacetylase (HDAC) enzymes, which are key regulators of chromatin 
condensation (Allis et al., 2007; Wang et al., 2009). Distinct from other histone 
modifications, lysine acetylation executes its functions by cumulative charge 
neutralization more than by lysine-specific acetylation effects (Martin et al., 2004; 
Zentner and Henikoff, 2013). 
Histone lysines can also be mono, bi or tri-methylated and, in contrast to lysine 
acetylation, histone methylation on specific lysine residues defines very different 
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activities, like activation or repression of transcription (Zentner and Henikoff, 2013), 
Histone methylation also plays a central role in defining the chromatin state of ESCs 
(see section 1.6). 
Finally, histones also undergo phosphorylation. This modification is triggered by 
many cellular processes, such as ATM-dependent serine phosphorylation of γ-
H2A.X in response to DNA double strand breaks (Paull et al., 2000). In response to 
DNA damage, histones can also be ADP-ribosylated, and this modification leads to a 
more relaxed chromatin state that is accessible to the DNA repair machinery 
(Messner and Hottiger, 2011). 
 
1.6 Chromatin state in ESCs 
The chromatin state of ESCs is different from both progenitor and fully differentiated 
cells. ESCs show less heterochromatic regions, which results in a more 
transcriptionally permissive chromatin state compared with differentiated cells. In 
addition, ESCs are characterized, typically on lineage regulatory gene promoters, by 
chromatin bivalency (Fig. 9) (Fisher and Fisher, 2011). Bivalent domains consist of 
regions marked by histone 3 lysine 27 trimethylation (H3K27me3) and histone 3 
lysine 4 trimethylation (H3K4me3). H3K4me3 is a mark of transcriptionally active 
chromatin, whereas H3K27me3 is a mark of transcriptional repressed promoters 
(Deaton and Bird, 2011; Smith and Meissner, 2013). 
H3K4me3 and H3K27me3 are deposited by Trithorax (Trx)/mixed lineage leukemia 
(Mll) and Polycomb proteins, respectively. In mammals, there are two Polycomb 
repressive complexes (PRC): PRC1 and PRC2. PRC2, via its catalytic subunit Ezh2, 
is responsible for H3K27 trimethylation, whereas PRC1 recognise H3K27me3 and 
 20 
mediates chromatin compaction and transcription silencing (Fisher and Fisher, 2011; 
Stock et al., 2007).   
It has been proposed that the coexistence of active and repressive marks on lineage 
regulatory gene promoters may keep genes repressed when under pluripotency 
conditions, but poises them to become activated in response to differentiation clues 
(Fisher and Fisher, 2011; Margueron and Reinberg, 2011; Mendenhall et al., 2010; 
Vastenhouw and Schier, 2012). 
 
Bivalency at gene regulatory regions is resolved either by loss of H3K27me3 and 
subsequent switch to fully transcription active gene, or by DNA methylation at 
cytosine residues and subsequent stable gene silencing. Bivalent DNA regions in 
ESCs are unmethylated and ESCs show an overall decrease in DNA methylation at 
CpG islands compared to more differentiated cells, although DNA methylation at 
non CpG islands is increased (Fig.9) (Fisher and Fisher, 2011; Ramsahoye et al., 
2000). During differentiation, cells opt for stable silencing of some genes and switch 
from bivalent chromatin to cytosine methylation. In mammals, four DNA methyl 
transferase (Dnmt) enzymes are assigned to establish DNA methylation: Dnmt1, 3a, 
3b and 3L. Dnmt1 is responsible for DNA methylation maintenance, but it has low 
affinity for unmethylated DNA regions and this limits its de novo methylation 
activity. Dnmt3a, Dnmt3b and Dnmt3L are deputed to de novo DNA methylation, 
although they are also important for methylation maintenance as evidenced by severe 
hypomethylation in Dnmt3a/3b null cells (Li et al., 1992; Okano et al., 1999; Smith 
and Meissner, 2013; Tsumura et al., 2006). Dnmt3a/3b act in complex with other 
chromatin compacting factors, such as histone methyltransferases and deacetylases, 
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to establish permanent gene suppression, whereas Dnmt3L does not have an 
enzymatic activity per se, but it interacts with, and stimulates the activity of Dnmt3a 




Figure 9. Schematic representation of chromatin conformation evolution during ESC 
differentiation.  In comparison with more differentiated cells, ESCs exhibit less extensive 
heterochromatin regions, an increase in non-CpG islands methylation and a decrease in CpG 
islands one. Furthermore, ESC chromatin is also characterized by bivalent domains. Chromatin 
bivalency is phased out during differentiation. Figure adapted from (Fisher and Fisher, 2011). 
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Improper DNA methylation at specific loci, such as pluripotency gene promoters, 
can affect maintenance of an undifferentiated state in ESCs. The enzymes deputed to 
demethylate cytosine residues are the ten-eleven translocation (TET) methyl-cytosine 
hydroxylase proteins: TET1, 2, 3. TET proteins can, through three subsequent 
reactions, convert 5-methyl cytosine into 5-hydroxymethylcytosine, then 5-
formylcytosine, and finally into 5-carboxylcytosine (Wu and Zhang, 2011).  
TET1, in particular, is important to maintain ESCs in an undifferentiated and self-
renewing state, thus preserving the Nanog promoter as active and unmethylated. 
Evidence in support of its crucial role in this process is that TET1-/- ESCs undergo 
spontaneous differentiation (Ito et al., 2010). Furthermore, TET1 is also important to 
establish ICM lineage specification, and in the reprogramming of differentiated cells 
into iPS cells. Specifically, it has been shown that TET1 interacts with Nanog, which 
can tether it to its target regions (e.g. the Oct4 and Esrrb promoters) (Costa et al., 
2013; Gao et al., 2013; Ito et al., 2010; Wu and Zhang, 2011). 
  
However neither DNA methylation nor bivalent domains are crucial to maintain 
pluripotency, although they are important for achieving and maintaining 
differentiation. In fact, although lack of H3K27me3 in ESCs leads to increase 
expression in some lineage commitment genes, cells remain undifferentiated. In 
addition, ESCs are also able to support global DNA hypomethylation, as evidenced 
by the ability of cells null for all three Dnmts to persist without defects in self-
renewal capacity and/or genomic instability (Schoeftner et al., 2006; Silva and 
Smith, 2008; Smith and Meissner, 2013; Tsumura et al., 2006).  
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1.7 Telomere function and biology  
Telomeres are specialized DNA-protein complexes that protect chromosome ends 
from inappropriately timed DNA repair activities such as homologous recombination 
and non-homologous end joining that can lead to genomic instability. Their average 
length changes during aging and is highly heterogeneous among different species, 
different individuals and even among different tissues and compartments in the same 
organism (Kipling and Cooke, 1990; Luke and Lingner, 2009; Palm and de Lange, 
2008; Smogorzewska and de Lange, 2002). In mus musculus, which possesses 
telomeres up to 100k bp (where the average human length at birth is 10k bp), a 
seven-protein complex (six in humans), named shelterin, associates specifically with 
telomeres and protects chromosome ends from a DNA damage response. Four 
shelterin proteins (three in humans, which have only one isoform of Pot1), TRF1, 
TRF2, POT1a and POT1b, are responsible for the direct recognition of telomeric 
sequence. They interact with TIN2, TPP1, and Rap1 to form the complete Shelterin 
complex (Chiodi et al., 2013; Hockemeyer et al., 2006; Palm and de Lange, 2008).  
Because telomeres become shorten with each cell cycle in somatic tissues that do not 
express telomerase, telomere length can regulate cellular lifespan in some cellular 
contexts. Telomere shortening, in fact, it has been associated with the famous 
experiments performed in 1961 by Leonard Hayflick, which showed how human 
cells in culture could proliferate only a certain number of times (Hayflick limit) 
before entering senescence. Therefore, cells need an efficient telomere maintenance 
system to prevent the attrition of their ends and consequent cellular senescence 
(Blackburn, 2001; Hayflick and Moorhead, 1961). 
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In the vast majority of cases, telomeres are elongated by telomerase. Carol Greider 
and Elizabeth Blackburn discovered this reverse transcriptase in 1984 while working 
with the ciliate Tetrahymena. Telomerase is composed of a catalytic subunit (Tert, 
telomerase reverse transcriptase) and an RNA component that serves as template 
(Terc, telomerase RNA). In mammals, telomeres bear the repeating sequence 5’-
TTAGGG-3’. Telomerase compensates for telomere erosion by adding TTAGGG 
repeats onto chromosome ends (Fig.10) (Geserick and Blasco, 2006; Greider and 
Blackburn, 1985). 
Telomerase is constitutively expressed in many unicellular eukaryotes. During 
mouse development, telomerase activity appears first in blastocyst. Telomerase is, in 
fact, a stemness hallmark; expression of telomerase in embryonic stem cells is 
sufficient to fully maintain telomere length (Liu et al., 2007; Shay and Wright, 
2010). During differentiation, its activity is largely (but not exclusively) limited to 
tissues characterized by a highly proliferative grade such as progenitor cell 
compartments (Liu et al., 2007). It also presents a dynamic regulation, as shown by 
variable and inducible levels during lymphocyte T maturation and activation (Weng 
et al., 1996). However, mouse somatic cells present a less strict suppression of 
telomerase activity compared to human somatic cells (Geserick and Blasco, 2006; 





Figure 10. Telomere elongation by telomerase in mammals. Telomerase binds chromosome ends 
by the annealing of Tert to telomere DNA. Using Terc as template for reverse transcription, 
Tert elongates telomeres by adding a repeating nucleotide sequence (TTAGGG). Adapted from 
(Granger et al., 2002). 
 
1.8 Tert: telomere commitment vs moonlight activities   
Apart from well-characterized, telomere-related, functions, Tert has been associated 
with several non-canonical activities. In 2008, Lee’s group reported that Tert 
overexpression in mouse neurons had an anti-apoptotic effect on N-mehtyl-D-
aspartic Acid (NDMA)-induced receptor mediated toxicity by entering the 
mitochondria and increasing calcium mobilization (Lee et al., 2008). 
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In addition, Steven Artandi and collaborators observed that Tert overexpression 
might lead, independently from telomere elongation, to mouse epidermal stem cell 
proliferation, self-renewal and migration by stimulating Wnt3a and c-Myc. Also, 
they noticed Wnt-associated development defects in Tert-/- mice (Choi et al., 2008; 
Park et al., 2009; Sarin et al., 2005).  
However, the hypothesis that Tert possesses non-canonical functions, when 
expressed at physiological levels, is still unclear. As one example, recent work from 
Carol Greider and colleagues focused on the analysis of Tert-+/- and Tert-/- mice. In 
this study they looked for Wnt pathway alteration and Wnt-dependent differentiation 
impairment, but they did not observe any difference between Tert-/- and wild-type 
animals (Strong et al., 2011). 
 
1.9 The role of telomere length in the regulation of telomere 
chromatin 
Mammalian telomeres and subtelomeric regions exhibit a highly compact chromatin 
conformation. In particular, both telomeric and subtelomeric regions are 
characterized by trimethylation of lysine 9 on histone H3 (H3K9me3) and 
trimethylation of lysine 20 on histone H4 (H3K20me3). In addition, subtelomeric 
DNA is also heavily methylated (Benetti et al., 2007; Gonzalo and Blasco, 2005). 
Telomere shortening and the presence of uncapped telomeres affect heterochromatin 
conformation at both telomeric and subtelomeric regions. Specifically, it has been 
observed, in mouse embryonic fibroblasts (MEFs) from late generation (G4) Terc-/- 
mice compared to Wt and G1 Terc-/- MEFs, that cytosine methylation is lost at 
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subtelomeric regions. At telomeric and subtelomeric regions in Terc-/- MEFs 
compared to Wt and G1 Terc-/- cells, the heterochromatin marks H3K9me3 and 
H4K20me3 are replaced with marks that are diagnostic of open chromatin, e.g. 
acetyl-H3K9 and acetyl-H4 (Benetti et al., 2007). 
These results indicate that telomere shortening and/or uncapped telomeres can trigger 
chromatin modifications, at least at within telomeric and subtelomeric regions.   
 
1.10 Alternative lengthening of telomeres and the role of 
telomere chromatin in the regulation of telomere length 
Besides telomerase, alternative telomere maintenance mechanisms exist. Although 
these ‘alternative lengthening of telomeres’ (ALT) mechanisms are not completely 
understood, they are typically associated with long and heterogeneous telomeres, 
extra-chromosomal telomeric DNA (both circular and linear), and ALT-associated 
promyelocytic bodies (APBs) which contain telomere binding proteins and proteins 
involved in DNA recombination and replication (Lafferty-Whyte et al., 2009; Royle 
et al., 2008a). ALT cells are also often characterized by loss of function mutation in 
the chromatin H3.3 assembling complex ATRX/DAXX (Bower et al., 2012). 
However, it is worth to mention that these characteristics are not only confined to 
telomerase-inactive cells. It is in fact been reported that both t-circles and telomere 
recombination can happen in normal cells harboring long telomeres (Neumann et al., 
2013; Pickett et al., 2009; Pickett et al., 2011). 
ALT mechanisms can occur in both pathological (tumour) and physiological 
(embryogenesis) contexts. Most human cancers (85%) gain unlimited replicative 
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potential through the reactivation of telomerase. In the remaining 15% of tumours, 
telomere maintenance occurs through the activation of ALT (Bryan et al., 1995; Kim 
et al., 1994).  
During embryogenesis, telomerase is absent or present at low levels in cleavage-
stage embryos, and becomes strongly activated in blastocysts. Interestingly, despite 
the lack of telomerase, telomeres are elongated considerably during the cleavage 
stage by an ALT-like mechanism characterized by long telomeres and extensive 
telomere sister-chromatid exchange (T-SCE) (Liu et al., 2007). 
In this regard, a recent study identified Zscan4c as a candidate protein involved in 
telomerase-independent telomere lengthening during embryogenesis (Zalzman et al., 
2010). However, role and mechanism of action of this protein at telomeres are still 
being elucidated.    
Furthermore, it has been shown that despite mouse embryonic stem cells shorten 
their telomeres from generation to generation of Terc-/- mice, ESCs from late 
generation (G4) Terc-/- mice maintain (without lengthening it though) the same 
telomere length of the previous generation (G3) (Huang et al., 2011). 
 
Although the mechanisms of the ALT pathway(s) are still undefined, previous 
studies have shown that ALT requires telomere-telomere recombination (i.e. T-SCE) 
(Dunham et al., 2000; Jiang et al., 2007; Murnane et al., 1994; Royle et al., 2008a).  
Recent studies in DNA methyl transferase-knockout mouse cells  (Dnmts-/-) (Benetti 
et al., 2008; Gonzalo et al., 2006a), and in human cells treated with demethylating 
agents (Vera et al., 2008), showed that hypomethylation of subtelomeric regions 
leads to increased T-SCE. On the other hand, the relationship between subtelomeric 
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hypomethylation and ALT does not seem to always hold in human cells (Tilman et 
al., 2009).  
. 
The discovery that telomeres are transcribed into long non-coding RNAs that remain 
associated with telomeric chromatin may offer new insight into the regulation of 
telomere length and the structure of telomeric chromatin (Azzalin et al., 2007). In 
fact, it has been proposed that this telomeric repeat-containing RNA (TERRA) may 
not only inhibit telomerase activity by pairing with the RNA component of 
telomerase (Terc) (Luke and Lingner, 2009), but could also play a role in the 
maintenance of telomere heterochromatin through the recruitment of heterochromatic 
factors such as DNA methyl transferase 3b (Dnmt3b) and Heterochromatin 




Figure 11. Schematic model for the formation of heterochromatin on mammalian telomeric and 
subtelomeric regions. Methylation of H3K9, on both telomeric and subtelomeric regions, 
generates a high-affinity site for HP1 (also recruited by TERRA), which in turn can recruit 
histone methyl-transferase (such as Suv4-20h) causing tri-methylation of H3K9 and H4K20. In 
parallel, DNA methylation by Dnmts, on subtelomeric regions, also contributes to 
heterochromatin formation. Adapted from (Schoeftner and Blasco, 2010). 
 
1.11 Telomeres and telomerase in embryonic stem cells 
Recently, few telomere-related proteins have been associated to ESC identity. In 
2010 for example, Minoru Ko and colleagues identified in the zinc finger and SCAN 
domain containing 4c (Zscan4c) one of the candidate factors involved in telomerase-
independent telomere elongation in cleavage stage of embryo development. In 
addition they found that in an ESC culture, Zscan4c localized at telomeres and was 
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transiently expressed by every cell, small proportion of cells per time, and its 
expression was associated to telomere recombination and elongation (Zalzman et al., 
2010). 
The Rap1 interacting factor 1 (Rif1), which is recruited on telomeres by the Shelterin 
protein Rap1, was instead identified as an important factor to maintain pluripotency 
in an RNAi screening study. Although its mechanism of action is still unclear, it was 
shown that Rif1 depletion led to ESC differentiation (Loh et al., 2006). 
 Rap1 itself, instead, has never been linked to ESC functions, so far, but lately it has 
been shown to possess gene regulation activities apart from telomere protection ones 
(Martinez et al., 2010).  
A further proof of the importance of telomerase and telomere regulation in ESCs is 
that during reprogramming of somatic cells to embryonic stem cells, telomerase is 
reactivated and telomeres acquire characteristics of ES cell telomeres (Marion et al., 
2009b). Notably, cellular reprogramming is impaired when cells have very short 
telomeres (G3-G4 Terc-/- MEFs) and telomerase is absent or non-functional (i.e. 
when it cannot elongate telomeres). Furthermore, all attempts to produce chimeric 
mice from telomerase-negative iPS cells (derived from G1, G2 or G3 Terc-/- MEFs) 
have failed (Marion et al., 2009b). 
In addition, it has been shown that ESCs from late generation (G3-G4) Terc-/- mice 
had an impaired ability to form teratoma and to contribute to chimeric animal 
formation after blastocyst injections (Huang et al., 2011).  
 
 The role of telomerase in the ability of ESCs to proliferate indefinitely, the putative 
telomere-unrelated Tert activities on stem cell biology, and the emerging functions of 
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telomere-related factors in gene expression and/or ESC identity, strongly pointed 
toward a major role of telomere biology in stem cell regulation.  
Furthermore, the importance of telomere length in iPS cell reprogramming, 
contribution to teratoma formation and animal chimerism upon blastocyst injections 
suggested a possible role of telomeres not only in preserving the replicative potential 
of the cell, but also in undergoing differentiation.   
In this study, we decided to question whether absence of Tert and/or telomere 






Materials and Methods 
2.1 Cell culture and transfection 
Cells employed in this study consisted of a wild type, paternal cell line of E14 ESCs 
(derived from R129J strain), and two separately generated Tert-/- ESC lines, 
produced by electroporating E14 ESCs with a targeting construct replacing five 
exons of mouse Tert with the neomycin resistance gene (Liu et al., 2000). After 
selection with G418 (0.3 mg/mL), homologous recombinants were identified and 
confirmed by southern blot and PCR (Liu et al., 2000). ESC lines were cultured on 
gelatin-covered dishes and maintained in Glasgow’s modified Eagle medium 
(GMEM; GIBCO) supplemented with 15% v/v fetal bovine serum (FBS), 0.055 mM 
b-mercaptoethanol (Sigma), 2 mM L-glutamine, 0.1 mM MEM nonessential amino 
acids, 5,000 units/ml penicillin/streptomycin, 1,000 units/ml LIF and doxycycline 1 
µg/ml, and maintained at 37°C with 5% v/v CO2. To restore Tert expression to Tert-/-
S ESCs, cells at passage 70 were co-transfected with pTRE-Bi-Tert-IRES-EGFP-
Hygro (or a similar vector lacking Tert) and CAG-rtTA advanced (pTET-ON 
advanced vector, Clontech). For constitutive expression of Tert, Tert-/-S ESCs were 
transfected with CAG-mTert-IRES-Puro or CAG-IRES-Puro. For expression of 
Dnmt3b, Tert-/-S ESCs were transfected with CAG-Dnmt3b-IRES-Puro or CAG-
IRES-Puro. All transfections employed Fugene6 (Roche) in a 3:1 ratio to DNA 
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according to the manufacturer’s instructions.  For Tert rescue or Dnmt3b 
reintroduction, cells were propagated for 4 passages under selection with 
hygromycin (500 µg/ml) or puromycin (5 µg/ml), and individual colonies were 
isolated. For Nanog shRNA transduction, cells were infected with commercially 
available lentiviral particles (Santa Cruz), and selected with puromycin (5 µg/ml). 
Cell transduction with Oct4 promoter-GFP was performed by infection with 
commercially available lentiviral particles (System Biosciences). All lentiviral 
infections were performed in presence of Polybrene (5 µg/ml) (Santa Cruz). All 
experiments were performed with more than one clonal isolate. 
2.2 Differentiation assay 
Cell populations of the indicated genotype (1 x 105) were plated in non gelatin-
covered dishes in LIF-free media containing 5 µM ATRA (Sigma) for the indicated 
amount of time, with ATRA-media replaced every 3 days. At the indicated time 
point, cells were re-plated in gelatin-covered dishes containing LIF-supplemented 
media. For the single colony formation assay, a set of serial dilutions was performed 
and the number of viable ES cell colonies assessed with alkaline phosphatase 
(Millipore). 
2.3 Quantitative fluorescence in situ hybridization (Q-
FISH) 
The Q-FISH protocol was carried out as described (Liu et al., 2000). Briefly, cells 
were treated with 0.2 µg/mL colcemid for 6 hours, harvested and resuspended in 0.5 
mL warm 75 mM KCl at 37 °C for 12 min with gentle stirring to prevent 
 35 
precipitation. Cells were spun at 128.7 x g for 5 min. The supernatant was discarded 
and cells were resuspended in 100 µL 75 mM KCl. One mL of 3:1 ice-cold 
methanol-acetic acid was added drop-by-drop to the cells, which were then incubated 
for 30 min at room temperature. Cells were spun as above, resuspended in an 
adequate volume of fixative and stored at -20°C for at least 6 hours before being 
dropped onto slides and left to air-dry overnight. The next day, cells were fixed in 
4% v/v paraformaldehyde (PFA), digested with 100 mg/mL pepsin for 10 min at 
37°C and dehydrated in ethanol (5 min in each of 70% v/v, 90% v/v and 100% v/v 
ethanol). Slides were air-dried and hybridized in the dark with a Tel-Cy3 PNA probe 
(Panagene) in hybridization solution (70% v/v formamide, 0.25% v/v blocking 
solution (Roche), 10 mM Tris-HCl pH 7.4, 0.5 µg/ml Tel-Cy3 PNA probe, 5% v/v 
MgCl2). Slides were then denatured at 80°C for 3 min, left in the dark for at least 2 
hours, then washed. DAPI was subsequently added. Metaphase spreads were 
captured using Metafer 4 software and analyzed using Isis software. Statistical 
analysis of telomere intensity distribution was performed using Welch’s unpaired t-
test.  The incidence of telomere-signal free ends was defined as the number of 
chromosome ends possessing a telomere signal (in arbitrary units) between 0 and 




Total RNA was isolated from cells using Triazol (Invitrogen) according to 
manufacturer’s instructions. Reverse transcription was carried out using 0.5 µg of 
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template RNA, random hexamer primers and smart MMLV reverse transcriptase 
(Clontech). Diluted cDNA (20 times) was subjected to real-time PCR analysis using 
a SYBR Green Mastermix (Roche) on a LightCycler480 system (Roche). 
Background values (no reverse transcriptase added) were subtracted, and values were 
normalized to GAPDH (n>3). Oligos employed are listed in Table 1. Statistical 
analysis was performed by ANOVA and related Dunnett’s test comparing every 
group with Wt values. 
 
2.5 Chromatin immunoprecipitation (ChIP) 
 ChIP experiments were performed as described (Bergmann et al., 2011), except 
phenol-chloroform was replaced with a Chelex-100 resin-based DNA isolation 
method described in (Nelson et al., 2006). Briefly: at day 0, protein-A covered 
magnetic beads (Thermo scientific) were aliquoted in 1.5 mL tubes (1 tube per IP, 20 
µL per tube). Beads were magnetically precipitated and incubated with 0.5 mL of 
0.5% v/v PBS/BSA for 30 min during rotation at 4°C. The supernatant was aspirated 
and beads were resuspended in 0.5 mL of RIPA-BSA (50 mM Tris-HCl pH 7.4, 1% 
v/v NP-40, 0.25% w/v Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 
1 µg/ml each of aprotinin, leupeptin and pepstatin, 1 mM Na3VO4, 1 mM NaF, BSA 
0.5% v/v). 5 µg of Ab were added to the resuspended beads and incubated for at least 
6h on rotation at 4°C.   
Cells (at least 5 x 106 per sample, including 4 test samples + IgG control) were 
harvested and spun at 1000 x g for 5 min. The cell pellet was then resuspended in 
PBS 1X (1 mL of PBS per million of cells). Formaldehyde was added to cells for 
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crosslinking at a final concentration of 1% v/v, and cells were incubated on a rocking 
plate for 10 min.  Formaldehyde was then quenched by adding glycine at a final 
concentration of 125 mM and incubating cells on a rocking plate for 5 min. Cells 
were then centrifuged at 3000 x g for 3 min at 4°C. Afterwards, cells were 
resuspended in TBS (1 mL per million cells) and aliquoted in 1.5 mL tubes (1 mL 
each) and precipitated at 3000 x g for 3 min at 4°C. After quick removal of 
supernatant, cells were resuspended in 1 mL of freshly prepared lysis buffer (10 mM 
Tris-HCl pH 7.4, 10 mM NaCl, 0.5% v/v NP-40, PMSF 1 mM, 1 nM aprotinin, 25 
mM pepstatin, 25 mM antipain, 25 mM chymostatin) and incubated for 10 min on 
ice. After lysis, cells were spun at 1000 x g for 3 min at 4°C and resuspended in 0.5 
mL of lysis buffer. 300 µL of dilution buffer 1 (50 mM Tris-HCl pH 7.4, 0.2 mM 
EDTA, 0.2% v/v SDS, 130 mM NaCl, 0.8% v/v triton-x 100, 0.1% v/v sodium 
deoxycholate, PMSF 1 mM, 1 nM aprotinin, 25 mM pepstatin, 25 mM antipain, 25 
mM chymostatin) were added to each sample. Samples were incubated on ice for 5 
min. Ice-cold samples were then sonicated for 50 cycles of 30 seconds, and 
precipitated at 20,800 x g for 10 min at 4°C. Three hundred µL of supernatant from 
each sample was then collected in a new tube and mixed with 1.2 mL of a buffer 
composed of 1/6 dilution buffer 1, 2.5/6 of RIPA buffer, and 2.5/6 of dilution buffer 
2 (50 mM Tris-HCl pH 7.4, 130 mM NaCl, 0.8% v/v triton-x 100, 0.1% v/v sodium 
deoxycholate). Ten percent (150 µL) of the resulting input sample was collected and 
frozen at -80°C. 
Meanwhile, dynabeads were magnetically isolated and washed twice with 
RIPA/BSA buffer. The supernatant was then removed and the beads incubated with 
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450 µL of the remaining input sample. Samples were incubated during rotation for 
16h at 4°C. 
At day 2, beads were magnetically isolated, supernatant was removed, and beads 
were washed twice with 1 mL of RIPA buffer, twice with 1 mL of RIPA-500 buffer 
(50 mM Tris-HCl pH 7.4, 1% v/v NP-40, 0.25% w/v Na-deoxycholate, 500 mM 
NaCl, 1 mM EDTA, 1 mM PMSF, 1 µg/ml each of aprotinin, leupeptin and 
pepstatin, 1 mM Na3VO4, 1 mM NaF) and once with 1 mL of Tris-EDTA. The 
supernatant was then removed and 0.1 mL of 10% w/v Chelex-100 resin (Bio-Rad) 
was added to each sample. In parallel, 10 µL of stored input for each sample was 
incubated together with 0.1 mL of 10% w/v Chelex-100. 
Samples were boiled at 95°C for 12 min to de-crosslink samples and then treated 
with 2.5 µL of 10 mg/mL RNase A for 30 min at 37°C. Samples were then treated 
with 2.5 µL of 10 mg/mL proteinase K for 1h at 55°C. To inactivate the proteinase 
K, samples were boiled at 95°C for 10 min. Finally, samples were quickly 
precipitated and the supernatant was stored at -20°C. 
DNA recovered from at least three biological replicates was analyzed by QRT-PCR 
as described above. For each pair of primers, triplicate measurements were taken, 
and normalized to input DNA and the amount of DNA recovered from the GAPDH 
promoter (n>3). Antibodies employed were: rabbit anti-Nanog (Bethyl labs); mouse 
anti-H3K27me3, anti-H3K4me3, anti-acH4, acH3K9 (Abcam) and anti-methyl 
cytosine (Millipore); and, as control, murine IgG (Sigma). Oligos employed are 
listed in Table 1. Statistical analysis was performed by ANOVA and related 
Dunnett’s test comparing every group with Wt values. In each experiment, the signal 
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present after immunoprecipitation with IgG was defined as background and 
subtracted prior to normalization to input DNA and GAPDH.  
 
2.6 Methylation assay 
 Relative genomic DNA methylation was assessed using the ELISA-based imprint 
methylated DNA quantification kit (Sigma) according to manufacturer’s instructions 
and using 100ng of genomic DNA per sample (n>3).  
 
2.7 Bisulphite sequencing analysis 
 DNA bisulphite conversion was performed as described (Clouaire et al., 2010). 
After bisulphite conversion of unmethylated cytosines to uracil, samples were 
resuspended in 1×Tris–EDTA for PCR amplification. PCR products were cloned into 
pcDNA3.1 (Invitrogen) vector, and colony PCR was performed. Clones (at least ten 
per sample) of the correct molecular mass were sequenced and results analyzed with 
BiQ Analyzer (http://biq-analyzer.bioinf.mpi-inf.mpg.de). Primers employed are 
listed in Table 1. Statistical analysis of samples employed Fisher’s exact test (two-
sided) using GraphPad Instat3 (www.graphpad.com). 
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2.8 Telomerase activity assay 
 The telomere repeat amplification protocol, TRAP, was conducted with the 
TRAPeze Telomerase Detection Kit, Chemicon International, according to 
manufacturer’s instructions. 
 
2.9. Plasmid construction 
The plasmid pTRE-Bi-Tert-IRES-EGFP-Hygro was constructed by amplification of 
Tert cDNA by PCR and cloning it into pTRE-Tight-Bi (Clontech) following 
digestion with EcoRI and SalI. IRES-EGFP sequence was obtained from 
pCAGMKOSiE (from K.Kaji) and inserted into pTRE-Tight-Bi (following digestion 
with SalI and EcorV) using SalI and HpaI sites and then inserted into pTRE-Bi-Tert 
using NotI sites. Finally, the hygromycin-resistance gene was cloned by PCR into the 
XbaI restriction site of pTRE-Tight-Bi and pTRE-Bi-Tert-IRES-EGFP vectors to 
create pTRE-Bi-EGFP-Hygro and pTRE-Bi-Tert-IRES-EGFP-Hygro. The pCAG-
rtTA-advanced vector was constructed by removal of the MKOS ORFs from 
CAGMKOSiE with EcoRI and BamHI and replacement with the advanced 
tetracycline reverse transactivator sequence (Clontech). The plasmid pCAG-Dnmt3b-
IRES-puromycin vector was constructed by removal of the MKOS ORFs from 
CAGMKOSiE with EcoRI. Dnmt3b was subcloned from a Dnmt3b expression vector 
(Thermo scientific) and inserted pCAG-IRES-EGFP following digestion EcoRI and 
SalI. IRES-EGFP was replaced with IRES-Puro (from pIRESPuro2, Clontech) after 
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digestion with PmlI and PvuII. Dnm3b was also subcloned in pTRE-Bi-Hygro using 
EcoRI and SalI sites. 
2.10 Fluorescence-activated cell sorting (FACS) 
 Hoechst stain (5µg/ml) was added to the cell culture and incubated for 30 minutes. 
Cells were harvested and resuspended in 0.5 ml of 1X PBS and analyzed for cell 
cycle distribution using a Becton Dickinson Fluorescence Activated Cell Sorter. 
After gating on the appropriate channels, the percentage of cells in G1, S, or G2/M 
were calculated. For FACS analysis of Nanog expression, cells were fixed and 
stained as indicated (Festuccia and Chambers, 2011).  Cell sorting after transduction 
with Oct4 promoter-GFP was carried out as described in (Zheng and Hu, 2012). 
 
2.11 Protein extraction and western blot analysis  
Histones were acid-extracted as follows: Cells were harvested and washed twice with 
ice cold 1X PBS. Cells were resuspended (107 cells/ml) in TEB buffer (PBS 1X, 
0.5% v/v Triton X-100, 2 mM PMSF, 0.02% v/v NaN3) and left on ice for 10 
minutes with gentle stirring to enhance lysis. Cells were spun at 800 x g for 10 
minutes at 4°C, washed in TEB buffer, and pelleted as above. Cells were 
resuspended in 0.2 N HCl (4 x107 cells/ml) and incubated overnight at 4°C. Cells 
were pelleted as above, and the supernatant was recovered and stored at -80°C. 
Protein extracts were resolved on 15% w/v SDS-PAGE, transferred to nitrocellulose 
and blocked overnight with 3% w/v BSA in 1X PBS. Rabbit anti-histone H3 
(Abcam) and mouse anti H3K27me3 (Abcam) were used as primary antibodies. 
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For non-histone protein extraction, cells were resuspended in Radio 
Immunoprecipitation Assay (RIPA) buffer (50 mM Tris-HCl pH 7.4, 1% v/v NP-40, 
0.25% w/v Na-deoxycholate, 0.1% v/v SDS, 150 mM NaCl, 1 mM EDTA, 1 mM 
PMSF, 1 µg/ml each of aprotinin, leupeptin and pepstatin, 1 mM Na3VO4, 1 mM 
NaF) and lysed for 30 minutes on ice. Cells were then quickly sonicated (10 cycles 
30 sec. On and 30 sec. Off), and put back on ice. RIPA buffer allows extraction of all 
cellular proteins, including membrane-bound ones, due to the combined use of ionic 
(SDS, Na-deoxycholate) and non-ionic (NP-40) denaturing agents, which disrupt 
protein-protein interactions, both at cell and nuclear membranes. Cells were then 
pelleted at 20,800 x g for 10 min at at 4°C. The supernatant was recovered and stored 
at -80°C. Protein extracts were resolved on 10% w/v SDS PAGE, transferred to 
nitrocellulose and blocked overnight with 5% w/v non-fat dry milk in 1X PBS. 
Rabbit anti-Nanog (Bethyl labs), anti-Dnmt3b (Abcam) and Dnmt1 (Abcam), goat 
anti-Oct4 (Santa Cruz) and mouse anti- β-Tubulin (Sigma) were used as primary 
antibodies. Anti mouse and anti rabbit peroxidase-conjugated were used as 
secondary antibodies followed by detection with ECL Plus luminescent reagent 
(Amersham Biosciences) or with LI-COR in which instance the secondary antibodies 
employed were donkey anti-rabbit IRDye 800CW (green) and donkey anti-mouse 
IRDye680 (red) (Odyssey). All experiments were repeated at least three times. 
 
2.12 Immunofluorescence 
Cells were fixed in 4% v/v paraformaldehyde (PFA)/PBS according to 
manufacturer’s instructions (Abcam). Rabbit anti-Nanog (Bethyl labs) and Alexa 
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fluor® Goat anti-rabbit-488 were used as primary and secondary antibodies. 
Rhodamine-phalloidin (Sigma) was used to detect actin. DNA was stained with 
DAPI. ImageJ software was employed to define the relative fluorescence intensities 
of single cells (for channels 488), with DAPI fluorescence as internal control. 
Individual values were used for quantitative analysis of Nanog expression levels 
among genotypes as described (Savarese et al., 2009). Statistical analysis was 
performed using Welch’s unpaired t-test.   
 
2.13 3D Analysis of Cell Nuclei 
 Cells were fixed in 4% v/v paraformaldehyde (PFA)/PBS for 15 min, then treated as 
described for Q-FISH analysis of telomere fluorescence. At least 25 interphase nuclei 
were analyzed for Wt, Tert-/-S and Tert-/-L. Images were acquired using a Nikon TE-
2000 microscope equipped with a 1.45 numerical aperture 100× objective, PIFOC Z-
axis focus drive (Physik Instruments), Sedat quad filter set, and CoolSnapHQ High 
Speed Monochrome charge-coupled device camera (Photometrics). Images were 
deconvolved from 0.2-µm sections using AutoquantX. Deconvolved images were 
analyzed for chromosome and telomere distribution using a macro described in 
(Korfali et al., 2010). 
 
2.14 Inhibition of p53 transcriptional activity  
Pifithrin-α (Sigma) was dissolved in DMSO at working concentration of 30 mM.  
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Cells were treated with 15-30 µM of Pifithrin-α (and equivalent volume of DMSO in 
control cells) and incubated 16h at 37 °C. After incubation cells were harvested, 
RNA extracted and analysed for Q-RT-PCR. 
 





Gata6F 5’-TGACCCAGGAGGGGGCGAGT-3’ 5’-CCGCCACCCAGGGCAGAAGA-3’ 
NanogF 5’-ACTCCAAGGCTAGCGATTCA-3’ 5’-AATAGGGAGGAGGGCGTCTA-3’ 
Oct4D  5’-CTGTAAGGACAGGCCGAGAG-3’ 5’-CAGGAGGCCTTCATTTTCAA-3’ 
Sub. Telo. Chr. 16B 5’-GATGGGATTTGGAAGGGTATT-3’ 5’-ACTCCCTAATTAACTACAACCCAT 
C-3’ 
QRT-PCR  Fw Rv 
Cdx2I 5’-CCTGCGACAAGGGCTTGTTTAG-3’ 5’-TCCCGACTTCCCTTCACCATAC-3’ 
Dnmt1 5’-TGGGCTGATGCAGGAGAAAAT-3’ 5’-GCGCTTCATGGCATTCTCCTT-3’ 
Dnmt3a2S 5’-AGGGGCTGCACCTGGCCTT-3’ 5’-TCCCCCACACCAGCTCTCC-3’ 
Dnmt3bSi 5’-TGGGATCGAGGGCCTCAAAC-3’ 5’-TTCCACAGGACAAACAGCGG-3’ 
EsrrbI 5’-CAGGCAAGGATGACAGACG-3’ 5’-GAGACAGCACGAAGGACTGC-3’ 
GAPDHF 5’-CCATCACCATCTTCCAGG-3’ 5’-CCTGCTTCACCACCTTCTTG-3’ 
Gata4F 5’-CTGTCATCTCACTATGGGCA-3’ 5’-CCAAGTCCGAGCAGGAATTT-3’ 
Gata6F 5’-TTGCTCCGGTAACAGCAGTG-3’ 5’-GTGGTCGCTTGTGTAGAAGGA-3’ 
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Klf4T 5’-AGTGTGACAGGGCCTTTCCAGGT-3’ 5’-AAGCTGACTTGCTGGGAACTTGAC 
C-3’ 











Sox2T 5’-TAGAGCTAGACTCCGGGCGATG   
A-3’ 
5’-TTGCCTTAAACAAGACCACGAA   
A-3’ 
Lin28F 5’-CGAAGCCTCAAGGAGGGTGA-3’ 5’-TGCATTCCTTGGCATGATGG-3’ 
INSRSo 5’-GACTTACAGATGGTTGGGCA-3’ 5’-AAGACCAACTGTCCTGCCAC-3’ 
IRS2So 5’-TCCGCGGCTGGAGTACTACGAG-3’ 5’-ACAGCAGTCGAGCGCGATCAC-3’ 





Zfp281F 5’-TGAGCCCAGGCACCCA-3’ 5’-TGGAGAGGTGAAGACAAGCTGA  
C-3’ 








Table 1. List of oligos employed in this study. Superscripts indicate first author initial 
(Benetti et al., 2007; Dahl et al., 2010; Fidalgo et al., 2011; Ivanova et al., 2006; Jia et 
al., 2011; Sinkkonen et al., 2008; Softic et al., 2012; Takahashi and Yamanaka, 2006). 




ESCs with short telomeres show 
dysregulation of pluripotency genes 
 
One of the most influential findings of the modern molecular biology era is the 
discovery that cells need to maintain a minimal telomere length to be able to 
maintain their proliferative capacity, which was established through the introduction 
of Tert into primary fibroblasts and their subsequent ability to completely and 
indefinitely bypass the Hayflick limit (Bodnar et al., 1998; Shay and Wright, 2010; 
Vaziri and Benchimol, 1998). Although telomerase is the primary factor responsible 
for telomere elongation and maintenance, other telomerase-independent lengthening 
mechanisms have been described both in physiological and pathological conditions 
(Liu et al., 2007; Royle et al., 2008b). In addition, it has also been shown that ESCs 
derived from late generation (G4) mice deficient for the telomerase RNA component, 
Terc, maintain a telomere length similar to the previous generation (Huang et al., 
2011). Finally, another factor to be considered is that Tert may have telomere-
unrelated functions that affect gene expression (Choi et al., 2008; Park et al., 2009). 
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This chapter aimed to test the effect of Tert deficiency and telomere shortening on 
ESC self-renewal and pluripotency gene expression using a wide range of 
biochemical and microscopy methodologies.  Importantly, we took advantage of 
specific genetic backgrounds: parental E14 ESCs (Wt); ESCs with disrupted Tert 
gene at late passage, and then with short telomeres (Tert-/-S); ESCs with disrupted 
Tert gene at earlier passage, and then with longer telomeres (Tert-/-L); and eventually 
Tert-/-S ESCs where Tert cDNA had been re-introduced (Tert-/-R). We hypothesized 
that the combination of these different genotypes would have enabled us to 
distinguish the impact of telomere integrity versus telomerase status on the 














3.1 Critically short telomeres lead to increased Nanog both 
at mRNA and protein levels 
First, we decided to investigate the effect of Tert deficiency on self-renewal. 
Initially, we characterized late passage (p70) Tert-/- ESCs (Tert-/-S) (Liu et al., 2000). 
These cells were negative for telomerase enzymatic activity (Fig. 12A) and exhibited 
telomere length shortening and a significant accumulation of uncapped (signal-free 
ends) telomeres relative to Wt cells at same passage. (Fig. 12B, p<0.0001, Fisher's 
exact test).  
 
Figure 12. Characterisation of telomerase activity and telomere length in Tert-/- ESCs. A) 
Telomere repeat assay protocol (TRAP) performed on protein extracts (the equivalent of 5 x 104 
cells) from Tert-/- ESCs (lane 1), Wt ESCs untreated (lane 2) or after digestion with ribonuclease 
A (lane 3). IC = internal PCR control. B) Q-FISH analysis of indicated genotypes; statistical 
significance was analysed by Welch’s unpaired t-test; S = short telomeres (passage 70); The 
difference in the incidence of signal-free ends relative to total ends between Tert-/-S (49/417) and 
Wt (2/382) was statistically significant (p<0.00001 for each comparison, Fisher's exact test). N = 
number of chromosome ends; y-axis, number of events; x-axis, telomere signal intensity in 




Despite telomere shortening and lack of telomerase activity, Tert-/-S did not show 
altered cell morphology or cell cycle distribution compared to Wt ESCs (Fig. 13A, 
13B) 
 
Figure 13. Characterisation of cell morphology and cell cycle distribution of Tert-/- ESCs. A) 
Bright field image of Wt and Tert-/-S cells. Micrograph bars indicate 200μm. B) Cell cycle 
profile of the same samples as in (A). 
 
We then investigated whether the observed telomere shortening and/or the absence 
of Tert might affect pluripotency gene expression. We used Q-RT-PCR to examine 
the mRNA levels of the pluripotency core transcriptional factors: Nanog, Oct4 and 
Sox2. Among these three genes, only Nanog resulted altered (an ≈ 4-fold increase) in 
Tert-/-S compared to Wt cells (Fig. 14). 
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Figure 14. Relative gene expression of Wt and Tert-/-S ESCs analysed by QRT-PCR. Data are 
represented as mean ± SD. *** = p<0.0001. Background values (no reverse transcriptase added) 
were subtracted, and values were normalized to GAPDH (n>3). Statistical analysis was 
performed by unpaired t-test. 
In order to confirm that the increased Nanog levels were Tert and/or telomere-length-
dependent, we reintroduced Tert into Tert-/-S cells using an expression vector under 
the control of the CMV early enhancer/chicken β actin (CAG) promoter (Fig. 15A). 
Transfected cells (Tert-/-R) exhibited the expected re-acquisition of telomerase 
enzymatic activity (Fig. 15B) and, after propagation for 4 passages in culture, also 
exhibited telomere lengthening and a significant reduction of uncapped telomeres 
(Fig. 15C, 15D). 
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Figure 15. Effect of Tert reintroduction into Tert-/-S ESCs on telomere length. A) Schematic 
representation of Tert expression vector. 1 x 105 Tert-/-S ESCs were transfected with Tert 
expression vector or empty vector and selected for puromycin resistance. B) TRAP assay 
performed on protein extracts (the equivalent of 5 x 104 cells) from Tert-/-R ESCs after digestion 
with ribonuclease A (lane 1), untreated Tert-/-R ESCs (lane 2), and untreated Wt ESCs (lane 3). 
IC = internal PCR control. B) Q-FISH analysis of indicated genotypes; statistical significance 
was analysed by Welch’s unpaired t-test; The difference in the incidence of signal free ends 
among Tert-/-S (49/417) and Tert-/-L (14/416) or Tert-/-R (4/417) was statistically significant 
(p<0.00001 for each comparison, Fisher's exact test). L = long telomeres (passage 30); S = short 
telomeres (passage 70); R = Tert-/-S cells after reintroduction of Tert (passage 74, including 4 
passages under puromycin selection). N = number of chromosome ends; y-axis, number of 
events; x-axis, telomere signal intensity in arbitrary units. D) Average of mean telomere signal 
intensity relative to Wt. Data are represented as mean ± SD (n=3); Number of chromosomes per 
sample ≥ 350. E) Relative gene expression of Tert in Wt, Tert-/-S, Tert-/-R (colony 1, indicated as 
Tert-/-R1) and Tert-/-R (colony 2, indicated as Tert-/-R2) ESCs analysed by QRT-PCR. Data are 
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represented as mean ± SD. Background values (no reverse transcriptase added) were 
subtracted, and values were normalized to GAPDH (n>2). The experiment in panel B was 
performed by Dr. Laura Gardano. 
 
In parallel, in order to distinguish whether putative effects on Nanog expression in 
Tert-/-R cells were due to non canonical Tert activities or to telomere lengthening, we 
examined Nanog mRNA levels in Tert-/- cells at earlier passage (p28) (Tert-/-L). We 
observed, both in Tert-/-R and in Tert-/-L a restoration of Nanog mRNA levels 
comparable to Wt  ESCs (Fig. 16). This result suggested that Nanog dysregulation 
was telomerase-independent and determined by critically short telomeres. 
 
Figure 16. Relative gene expression of Wt, Tert-/-S, Tert-/-L and Tert-/-R ESCs analysed by QRT-
PCR. Data are represented as mean ± SD. * = p<0.005 ** = p<0.001 *** = p<0.0001. 
Background values (no reverse transcriptase added) were subtracted, and values were 
normalized to GAPDH (n>3). Statistical analysis was performed by ANOVA and related 
Dunnett’s test comparing every group with Wt values. 
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We then tested if Nanog was altered at the protein level. The results were consistent 
with Q-RT-PCR, and an increase in Nanog protein levels was observed in Tert-/-S 
compared to Tert-/-L, Tert-/-R, and Wt cells (Fig. 17A, 17B). Oct4 results were also 
consistent with Q-RT-PCR showing no significant alteration among genotypes (Fig. 
17B). Finally, Tert-/-S cells were transfected with CAG-Tert-IRES-Egfp or control 
vectors for 72 hours, an interval of time insufficient to elicit telomere extension, and 
sorted for EGFP by FACS. No difference in Nanog levels was observed between 
Tert transfected and control cells. These results further confirmed that the Nanog 
increase in Tert-/-S cells is independent from non-canonical Tert activities (Fig 17C). 
 
Figure 17. Effects of telomere shortening on Nanog protein expression. A) Nanog protein 
expression, with Li-Cor quantification (n=3). Error bar indicates SD; L = long telomeres 
(passage 30); S = short telomeres (passage 70); R = Tert rescue (70 passages, followed by clonal 
selection and a further 4 passages after Tert re-introduction). The numeric superscripts 1 and 2 
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indicate two independently generated Tert-/-R colonies. EV = empty vector. B) Oct 4 and Nanog 
protein detection by western blot. β -Tubulin was used as an internal control (Tub). L = long 
telomeres (passage 70); S = short telomeres (passage 30); n=3 for Oct4 blot,  n=10  for Nanog 
blot. C) Nanog expression in Tert-/-S  ESCs 72h post-transfection with CAG-Tert-IRES-EGFP or 
CAG-IRES-EGFP vectors and cell sorting for EGFP-positive cells. 
 
3.2 Tert-/- cells exhibit an altered Nanog-High/Nanog-Low 
population distribution and pluripotency gene regulation  
The ability of ESCs to maintain self-renewal and respond to differentiation signals 
has been correlated with heterogeneity in the expression of particular pluripotency 
transcription factors such as Nanog. In particular, cells expressing high levels of this 
factor are prone to self-renew, whereas cells expressing low levels of this protein 
tend to differentiate (Chambers et al., 2007; Savarese et al., 2009).  
To assess whether Nanog upregulation in Tert-/-S ESCs was reflected in an altered 
heterogeneity of protein expression, we performed FACS analysis on Wt, Tert-/-S and 
Tert-/-R ESCs Wt and Tert-/-R ESCs showed a lower percentage of Nanog-high 
expressing cells, and a higher percentage of Nanog-low expressing cells compared to 





Figure 18.  FACS analysis of Nanog expression in Wt, TERT-/-S and Tert-/-R. Note the rightward 
shift and increase in average Nanog signal intensity in Tert-/-S ESCs. The red line indicates the 
mean value of Nanog expression in Wt ESCs. 
 
We also examined the level of expression of other genes involved in the Nanog 
regulatory network  (Tbx3, Esrrb and Rex1) (Festuccia et al., 2012; Ivanova et al., 
2006; Shi et al., 2006), comprising factors that have a negative impact on Nanog 
expression (i.e. Zfp281) (Fidalgo et al., 2011), and markers of lineage differentiation  
such as Cdx2 and the directly negatively regulated by Nanog endoderm markers 
Gata6 and Gata4 (Singh et al., 2007). As expected, the mRNA levels of Rex1, Esrrb 
and Tbx3 increased in Tert-/-S ESCs, where Zpf281 and Cdx2 levels remained 
unaltered (Fig. 16). However, the levels of Gata6 and Gata4 were also increased 
(Fig. 19).  
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Figure 19. Relative gene expression in Wt, Tert-/-S, Tert-/-L and Tert-/-R ESCs analysed by QRT-
PCR. Data are represented as mean ± SD. * = p<0.005 ** = p<0.001. Background values (no 
reverse transcriptase added) were subtracted, and values were normalized to GAPDH (n>3). 
Statistical analysis was performed by ANOVA and related Dunnett’s test comparing every 
group with Wt values. 
 
3.3 Tert-/- cells show impaired Nanog repression capability 
The increased expression in Tert-/-S ESCs of negatively regulated targets of Nanog 
induced us to investigate the capacity of Nanog to occupy specific promoters. 
Consistent with our previous observations, chromatin immunoprecipitation (ChIP) 
analysis revealed lower levels of Nanog occupancy on the Gata6 promoter (Fig. 20). 
Nevertheless, Nanog recruitment on its own promoter, which represses its own 
expression (Fidalgo et al., 2011), increased in Tert-/-S ESCs (Fig. 20). Thus, the 
increased expression of Nanog is not the consequence of impaired occupancy of 
Nanog on its own promoter.  
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Figure 20. (Left) ChIP analysis using an antibody to Nanog in Wt, Tert-/-S and Tert-/-R cells. 
Relative enrichment was quantified using region specific qPCR primers for Nanog (top) and 
Gata6 (bottom) promoters. Generic IgG was used as a control (n=3).  Statistical analysis was 
performed by ANOVA and related Dunnett’s test comparing every group with Wt values Error 
bars indicate SD. * = p<0.05; *** = p<0.0001. (Right) Map of DNA region amplified by 
QRTPCR after chromatin immunoprecipitation. The red box indicates the position of primer 
annealing region (PAA) relative to the transcriptional starting site (TSS).  
 
3.4 Summary of chapter 3  
In this chapter we characterized Tert deficient ESCs with short telomeres for cell 
cycle distribution, cell morphology and pluripotency gene expression. We found that, 
although Tert-/-S cells maintained similar morphological characteristics and and a cell 
cycle profile comparable to Wt ESCs, they presented altered expression of genes 
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involved both in pluripotency (e.g. Nanog, Esrrb, etc.) and differentiation (e.g. 
Gata6, etc.). We showed that Tert-/-S ESCs possess an increased population of 
Nanog-high cells, and that, in these cells, Nanog repression capability seems to be 
impaired. Finally, we confirmed that the above-mentioned effects are due to 











Tert-/-S ESCs display epigenetic 
alterations at telomere proximal and 
distal loci 
 
The results in chapter 3 led us to investigate whether epigenetic, transcriptionally 
active and repressive marks (i.e. H3K4me3 and H3K27me3) were also affected by 
telomere shortening. It has been reported that telomere shortening may induce loss of 
heterochromatin marks and DNA methylation at subtelomeric regions (Benetti et al., 
2007). In addition, it is known that low levels of trimethylation on H3K27me3 lead 
to increase number of Nanog-high expressing cells, as well as to promote Gata6 
expression (Lu et al., 2011; Shen et al., 2008; Villasante et al., 2011). Thereby, using 
western blot and ChIP, we investigated these aspects of epigenetic regulation in Tert-
/-S cells.  
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4.1 Alteration of histone marks in Tert-/-S cells  
First, we decided to analyse the enrichment of “open” chromatin marks at 
subtelomeric regions. Subtelomeric regions are segments of DNA placed just before 
telomeres. They are characterized by repetitive sequences of DNA, mostly 
(TTAGGG)-like sequences, and tend to be heavily heterochromatic (Gonzalo et al., 
2006b). We focused on the subtelomeric region of the q arm of the chromosome 16, 
since it has been reported that this region is widely heterochromatic in physiological 
conditions and that telomere shortening leads to an increased enrichment of acetyl-
histone 4 (acH4) and acetyl-histone-3-lysine 9 (acH3K9) on it (Benetti et al., 2007; 
Gonzalo et al., 2006b). As expected, we found a higher enrichment of these 
epigenetic marks in the in Tert-/-S cells compared to Tert-/-R and Wt ESCs (Fig. 21). 
These results confirmed the hypothesis that chromatin conformation at region 
proximal to telomeres is affected by telomere length. 
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Figure 21. (Top) ChIP analysis using antibodies to acetyl H3K9 (left) and acetyl H4 (right) in 
Wt, Tert-/-S and Tert-/-R ESCs. Relative enrichment was quantified using region specific qPCR 
primers for chromosome 16, subtelomeric region. Generic IgG was used as a control (n=3).  
Statistical analysis was performed by ANOVA and related Dunnett’s test comparing every 
group with Wt values Error bars indicate SD. * = p<0.05; ** = p<0.01. (Bottom) Map of DNA 
region amplified by QRTPCR after chromatin immunoprecipitation. The red box indicates the 
position of primer annealing region (PAA) relative to the loci on chromosome 16q.  
 
We then aimed to investigate whether chromatin conformation at telomere distal loci 
was also perturbed by critically short telomeres. For that purpose, we tested the 
levels of H3K4me3 for Nanog and Oct4 promoters and H3K27me3 for the promoter 
regions of Nanog, Oct4 and Gata6. We observed that, although the total level of 
H3K27me3 is slightly higher in Tert null cells, its enrichment on both Gata6 and 
Nanog promoters is lower compared to Wt and Tert rescue cells (Fig. 22A, 22D). We 
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could not detect H3K27me3 enrichment on the Oct4 promoter (Fig. 22A). H3K4me3 
levels were unaffected by telomere shortening in both loci (Fig 22B). These data 




Figure 22. ChIP analysis using antibodies to acetyl H3K4me3 and H3K27me3. A) H3K27me3 
relative enrichment on Nanog, Gata6 and Oct4 promoters in Wt, Tert-/-S and Tert-/-R ESCs. B) 
H3K4me3 relative enrichment on Nanog and Oct4 promoters in Wt, Tert-/-S and Tert-/-R ESCs. 
Generic IgG was used as a control (n=3).  Statistical analysis was performed by ANOVA and 
related Dunnett’s test comparing every group with Wt values Error bars indicate SD. ** = 
p<0.01. C) Map of DNA region amplified by QRTPCR after chromatin immunoprecipitation. 
The red box indicates the position of primer annealing region (PAA) relative to the 
transcriptional starting site (TSS). D) Detection of H3K27me3 and total histone H3 (as a 
control) by western blot (n=3).  
It is known that chromatin conformation may affect chromosome localization (Dostie 
and Bickmore, 2012). Considering the alteration in the enrichment of chromatin 
marks in ESCs with short telomeres, we decided to investigate whether this could 
lead to a re-localization of chromosomes into the nucleus. In order to address this 
question, we performed a FISH-based 3D analysis of cell nuclei. We then analysed 
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chromatin distribution (assessed by DAPI intensity) and telomere distribution 
(assessed Cy3 telomeric probe) of Wt and Tert ESCs with long or short telomeres 
(Fig. 23). However, we did not observe any difference in either chromatin or 
telomere distribution among genotypes. 
 
Figure 23. 3D-analysis of cell nuclei. DAPI and Cy3 telomeric probe FISH-stained nuclear 
images were analysed for chromatin and telomere distribution using a macro described in 
(Korfali et al., 2010), which divided the nuclear area in 5 equal concentric zones, where 1 is the 
inner one and 5 the most peripheral zone. Y-axis indicates the percentage of signal in each zone.  
 
4.2 Telomere shortening leads to DNA hypomethylation 
induced by de novo DNA methyltransferase downregulation  
Given the long-range effects of short telomeres on gene expression and histone post-
translation modifications, we analysed whether DNA methylation was also affected 
in cells with critically short telomeres.  As a starting point, since is known that 
telomere length can affect DNA methylation at subtelomeric regions (Benetti et al., 
2007) we used ChiP to examine the enrichment of methyl-cytosine at subtelomeric 
regions of chromosome 16. Accordingly to what was previously described, we found 
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a loss of DNA methylation in ESCs with short telomeres (Fig. 24A) (Benetti et al., 
2007). We next asked whether Tert-/-S ESCs might also possess an altered global 
genomic DNA methylation profile. Contrary to other cell types, ESCs can tolerate 
severe hypomethylation and retain proliferative capacity, although it leads to 
impaired differentiation and differentiation maintenance capability (Feldman et al., 
2006; Jackson et al., 2004; Sinkkonen et al., 2008; Tsumura et al., 2006).  We 
performed an ELISA-based assay to obtain a relative quantification of genomic DNA 
of Wt, Tert-/-S and rescue ESCs. We observed a significant decrease in DNA 
methylation in Tert-/-S cells compared to Wt (approximately 70%) and Tert-/-R cells 
(approximately 50%), (Fig. 24B). This result suggested that telomere length has an 




Figure 24. DNA methylation analysis in Wt, Tert-/-S and Tert-/-R ESCs. A) (Top) Methyl cytosine 
(Cytme) relative enrichment, analysed by ChIP, on chromosome 16 subtelomeric region. 
Relative enrichment on Nanog, Gata6 and Oct4 promoters. Generic IgG was used as a control 
(n=3).  Statistical analysis was performed by ANOVA and related Dunnett’s test comparing 
every group with Wt values. (Bottom) Map of DNA region amplified by QRTPCR after 
chromatin immunoprecipitation. The red box indicates the position of primer annealing region 
(PAA) relative to the loci of chromosome 16q.  B) Relative quantification of global DNA 
methylation (n=3). Analysis performed by an ELISA-based assay for methyl cytosine. Error 
bars indicate SD. * = p<0.05 
 
One possible mechanism for the observed DNA hypomethylation in Tert-/-S cells 
might be an alteration in the expression of enzymes responsible for CpG 
methylation. In mammals, genomic DNA methylation is principally regulated by 
three CpG DNA methyl transferases (Dnmts): Dnmt1 (responsible for DNA 
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methylation maintenance), and the de novo methyl transferases Dnmt3a and Dnmt3b 
(Li et al., 1992; Okano et al., 1999; Tsumura et al., 2006). We therefore tested Wt, 
Tert-/-S and Tert-/-R ESCs for altered expression of Dnmts. We did not notice any 
difference in Dnmt1 expression among the different cell lines (Fig. 25A). However, 
we observed a strongly reduced expression of the de novo Dnmt3a2 (predominant 
isoform in ESCs) and Dnmt3b both at RNA and protein level in Tert-/-S cells 
compared to Wt and Tert-rescued cells (Fig. 25A, 25B).  
 
Figure 25. Dnmt expression analysis in Wt, Tert-/-S and Tert-/-R. A) Relative gene expression of 
Dnmt1, Dnmt3b and Dnmt3a2 analysed by QRT-PCR. Values were normalized to GAPDH 
(n=4). Error bars indicate SD. Statistical analysis was performed by ANOVA and related 
Dunnett’s test comparing every group with Wt values. * = p<0.05, ** = p<0.01, *** = p<0.0001. 
B) (Top) Dnmt3b protein detection by western blot and (bottom) following Li-Cor 
quantification (n=3). Lane 3 indicates Tert-/-S ESCs transfected with Dnmt3b and propagated for 
60 days (see chapter 4.3). Error bars indicate SD. 
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4.3 Enforced expression of Dnmt3b in Tert-/-S cells restores 
Nanog to levels comparable to Wt ESCs 
While the decreased levels of Dnmt3a and 3b in Tert null ESCs could explain the 
mechanism for DNA hypomethylation in ESCs with short telomeres, these 
perturbations may also be the indirect result of changes in gene expression induced 
by critically short telomeres. To distinguish between these possibilities, we tested 
whether the enforced re-expression of Dnmt3b was sufficient to elicit a change in 
global DNA methylation or H3K27 enrichment at the Nanog promoter. It is in fact 
been shown how severe DNA hypomethylation may lead to redistribution of 
H3K27me3, with an increase on usually methylated DNA regions and a decrease on 
typically unmethylated ones (e. g. pluripotency gene promoters) (Brinkman et al., 
2012). We selected for ESCs that expressed the Dnmt3b cDNA under the CAG 
promoter in Tert null ESCs (Tert-/-3b) (Fig. 25B). Dnmt3b detection by western blot 
results in two bands of the approximate molecular weight of 100 kDa (the expected 
migration size of Dnmt3b). This may suggest the detection, by the antibody, of an 
unspecific band. However, although it is not possible to completely exclude this 
theory without further experiments (i.e. to add a peptide tag to the protein), the fact 
that exogenous expression of Dnmt3b cDNA leads to an increase of both bands 
seems to dismiss this hypothesis. The Dnmt3b cDNA exogenous expression rather 
suggests a situation where either A) Dnmt3b undergoes post-transcriptional 
modifications detectable by western blot, or B) the two bands belong to two isoforms 
and the exogenous expression of Dnmt3b cDNA positively modulates the expression 
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of the endogenous gene, or the stability of the endogenous isoforms, resulting in an 
increased expression of both these isoforms. 
 After 60 days post transfection, ESCs with critically short telomeres that expressed 
Dnmt3b comparable to Wt ESCs exhibited a partial restoration of global DNA 
methylation and H3K27 enrichment on Nanog promoter and reduced the level of 
Nanog expression closer to Wt (Fig. 26A, 26B, 26C). Therefore, it appears that 
reduced Dnmt3b expression (possibly in cooperation with Dnmt3a or Dnmt3L—see 
Discussion on session 7.2) is directly linked to the defect in DNA methylation 
observed in Tert null ESCs with short telomeres. 
 
 
Figure 26. Effects of enforced Dnmt3b expression in Tert-/-S ESCs on global methylation and 
Nanog expression. A) Relative quantification of global DNA methylation (n=3). Analysis 
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performed by an ELISA-based assay for methyl cytosine. B) (Top) H3K27me3 relative 
enrichment in Wt, Tert-/-S,  Tert-/-R and Tert-/-3b, analysed by ChIP, on Nanog promoter region. 
Generic IgG was used as a control (n=3).  Statistical analysis was performed by ANOVA and 
related Dunnett’s test comparing every group with Wt values. (Bottom) Map of DNA region 
amplified by QRTPCR after chromatin immunoprecipitation. The red box indicates the position 
of primer annealing region (PAA) relative to the transcription starting site (TSS). C) Detection 
of Nanog and tubulin (as a control) by western blot (n=3). Error bars indicate SD. * = p<0.05,  * 
*= p<0.01,  *** = p<0.0001 
 
4.4 Summary of chapter 4  
In this chapter we assessed the epigenetic regulation of DNA methylation and 
histone post-translational modification in Tert null ESCs with critically short 
telomeres. We found, as already reported, a gain of open chromatin marks (e.g. 
acH4, etc.) and a loss of DNA methylation at subtelomeric regions (Benetti et al., 
2007). Interestingly though, we also found epigenetic alteration at loci distant form 
telomeres in Tert-/-S cells. We found that in ESCs with critically short telomeres, 
despite a global H3K27me3 increase, the promoter regions of Nanog and Gata6 
exhibited a reduced enrichment of this transcriptional repressive mark. Finally, we 
revealed how DNA hypomethylation is not confined to subtelomeric regions, but 
affects the whole genome. These effects were ameliorated via the restoration of 
Dnmt3b expression in Tert null ESCs with short telomeres. Altogether these results 
indicate that telomere shortening can affect chromatin conformation even at loci 





Delayed and metastable 
differentiation of ESCs with 
critically short telomeres 
 
Our observations that ESCs with short telomeres exhibited an increased proportion 
of Nanog-high cells, a displacement of chromatin repressive marks, and a decrease in 
de novo Dnmt expression led us to speculate that differentiation could be affected 
stem cells with critically short telomeres. In this chapter, we tested the kinetics and 
stability of lineage commitment and differentiation in Tert-/-S ESCs compared to Wt  




5.1 Delayed response to ATRA treatment and re-gain of 
pluripotency after LIF 
To test if pluripotency gene dysregulation in Tert-/-S ESCs affected the response to 
differentiation signals, we treated Wt, Tert-/-S and Tert-/-R ESCs with 5 µM all-trans 
retinoic acid (ATRA) for 6 days in a LIF-free media, followed by removal of ATRA 
and re-addition of LIF to the media. Contrary to Wt and Tert-/-R ESCs, after ATRA 
removal Tert-/-S ESCs exhibited a delayed acquisition of properties consistent with a 
differentiated state, and were prone to reacquire a stem cell-like morphology when 





Figure 27. Bright field images of Wt, TERT-/-S and TERT-/-R ESC populations at day 0 and 6 in 
media containing 5μM all-trans retinoic acid (ATRA) and, following ATRA removal, a further 
6 days in LIF-containing media. Micrograph bar indicates 200μm.   
Differentiated cells cannot spontaneously de-differentiate by simple addition of LIF, 
and 6 days of 5µM ATRA treatment have been shown to be sufficient to irreversibly 
differentiate ESCs (Sinkkonen et al., 2008; Takahashi and Yamanaka, 2006). 
Consistently with literature, Wt ESCs treated for 6 days with ATRA, and re-placed 
for additional 6 days in LIF-containing medium, maintained repression of 
pluripotency genes (i.e. Nanog). In contrast, immunofluorescence and western blot 
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analysis revealed that Tert-/-S cells were unable to sustain Nanog repression when LIF 
was re-added to the media after ATRA treatment (Fig. 28). 
 
Figure 28. Nanog detection in Wt, Tert-/-S and Tert-/-R ESCs treated for 6 days with all trans 
retinoic acid and for 6 days with LIF. (Left), Nanog immunofluorescence analysis (green = 
Nanog; Red = Actin). (Right), Nanog protein detection by western blot. Tub=β -tubulin (n=3). 
We asked whether the impaired differentiation of Tert-/-S ESCs might be due to 
inadequate downregulation of transcriptional factors involved in the maintenance of 
pluripotency and self-renewal. QRT-PCR analysis revealed that Nanog, Oct4 and 
Sox2 mRNA levels were elevated in Tert-/-S ESCs compared to Wt and Tert rescue 
cells after ATRA treatment, and were further up-regulated upon re-addition of LIF 
(Fig. 30). Perhaps not surprisingly, mRNA expression was a more sensitive read-out 
of the stability of the differentiated state, since Nanog protein levels were 
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undetectable after ATRA treatment (Fig 25A, 25B). These results suggest that short 
telomere ESCs were able to execute only an incomplete, transitory repression of 
pluripotency genes under differentiation conditions. 
 
Figure 30. QRT-PCR analysis of pluripotency genes after ATRA-induced differentiation. Gene 
expression at day 0 was arbitrarily set as 100 and the expression through the time course was 
normalized to mRNA levels at day 0. Values were expressed as a ratio to GAPDH. N=3. 
 
Next, we performed a single colony formation assay to assess the percentage of cells 
that were able to form ES colonies when cultured in LIF-containing media after 
ATRA treatment. As expected, no ES colony was observed in Wt and Tert-/-L ESCs 
after ATRA removal and LIF re-addition, which indicates the population had become 
differentiated (Fig. 31). However, Tert null ESCs with short telomeres exhibited a 
significant colony growth potential after 12 days in LIF-containing media (Fig. 31). 
This phenotype was rescued upon telomere elongation after re-introduction of Tert, 
which suggests that critically short telomeres impeded the ability of cells to remain 





Figure 31.  Single colony formation assay after ATRA treatment (6 days) and LIF-containing 
media (6 days) (n=3). A set of serial dilutions was performed and the percentage (n≥300) of 
viable ES cell colonies assessed with alkaline phosphatase assay. The difference in the incidence 
of colony formation between Tert-/-S and all the other genotypes was statistically significant 
(p<0.0001; ANOVA and related Dunnett’s test comparing every group with Tert-/-S values). 
Error bars indicate SD. N=3. Wt= Wild type (parental ESC population); Tert-/-S = Tert 
deficient ESCs with short telomeres; Tert-/-R = Tert deficient ESCs with short telomeres, where 
Tert cDNA has been reintroduced; Tert-/-L = Tert deficient ESCs with long telomeres. 
 
We further confirmed the link between telomere length and ability to maintain stable 
differentiation by testing the response to ATRA, and subsequent LIF re-addition, on 
Tert-/- ESCs with long telomeres. Tert-/-L cells were able to maintain suppression of 
pluripotency genes, and were unable to form ES colonies after ATRA treatment and 
LIF re-addition (Fig. 32A, 32B). 
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Figure 32.  The response of Tert-/-L ESCs to ATRA and subsequent LIF treatment. A) Nanog 
protein detection by western blot. Tub=β -tubulin (n=3). B) QRT-PCR analysis of pluripotency 
genes after ATRA-induced differentiation. Gene expression at day 0 was arbitrarily set as 100 
and the expression through the time course was normalized to mRNA levels at day 0. Values 
were expressed as a ratio to GAPDH.  
 
We took into consideration the possibility that telomere deficiency and the existence 
of short telomeres might select against development of differentiation events, and 
thus inhibit the appearance of differentiated cells. To further examine this point, we 
performed a longer time course of ATRA treatment (Fig. 33). Indeed, Tert-/-S ESCs 
require a longer time to suppress pluripotency gene transcription. 
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Figure 33. QRT-PCR analysis of pluripotency genes after ATRA-induced differentiation. Gene 
expression at day 0 was arbitrarily set as 100 and the expression through the time course was 
normalized to mRNA levels at day 0. Values were expressed as a ratio to GAPDH. 
 
To assess to what extent ATRA-treated cells were able to support colony formation 
(without re-addition of LIF-containing media), we plated Tert-/-S ESCs after 6 days of 
ATRA treatment followed by 6 days in LIF-free media, and observed a very reduced 
colony formation capacity, compared with cells growth in LIF-containing media 
(Fig. 34).  
 79 
 
Figure 34.  Single colony formation assay after ATRA treatment (6 days) and, where indicated, 
of LIF-containing media (6 days) (n=3). A set of serial dilutions was performed and the 
percentage (n≥300) of viable ES cell colonies assessed with alkaline phosphatase assay. The 
difference in the incidence of colony formation between Tert-/-S (after LIF re-addition) and all 
the other genotypes (and Tert-/-S without LIF re-addition) was statistically significant (p<0.0001; 
ANOVA and related Dunnett’s test comparing every group with Tert-/-S values). Error bars 
indicate SD. N=3. 
 
We sought to independently verify this result by transducing lentiviral particles 
containing GFP under control of the Oct4 promoter into Tert-/-S and Wt cells. After 
selection, cells were treated with ATRA for 12 days and then sorted for GFP-
negative cells by FACS. GFP-negative cells (after sorting) were re-plated in LIF-
containing media and analysed again for GFP expression (by microscopic analysis) 
10 days later. The results showed clearly that, apart from a small percentage, Tert-/-S 
cells were competent to suppress GFP after ATRA treatment. However, they also 
showed that GFP-negative selected Tert-/-S cells were able to reacquire significant 
levels of GFP expression after cultured in LIF-containing media and thus could not 
stably maintain differentiation (Fig. 35). 
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Figure 35. Oct4-promoter-driven GFP expression analysis of Wt and Tert−/−S ESCs post-ATRA 
treatment and after cell sorting for GFP-negative cells. Wt and Tert−/−S ESCs were transduced with a 
vector expressing GFP under the control of Oct4 promoter. Cells were treated with ATRA for 12 days 
and then sorted by FACS between GFP-positive 9 (green dots) and GFP-negative (black dots) cells. 
The upper graph shows the percentage of GFP-positive cells determined by FACS after 12 days of 
ATRA treatment. The lower chart shows the percentage of GFP-positive cells derived from sorted 
GFP-negative cells plated in LIF-containing media for 10 days. The difference in the incidence of 
GFP-positive cells, between Tert−/−S and Wt cells, was statistically significant (p < 0.0001; Welch’s 
unpaired t test). Data are represented as mean ± SD. 
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5.2 Impairment of pluripotency gene promoter methylation 
after retinoic acid stimulation, and Dnmt3b-induced 
differentiation rescue 
Methylation of CpG islands of pluripotency gene promoters is a key step in 
differentiation process (Altun et al., 2010). We used DNA bisulphite sequencing to 
test whether short telomere cells would exhibit an altered methylation profile of 
Nanog and Oct4 promoters. In undifferentiated conditions, the promoters of all cell 
genotypes were entirely or almost entirely unmethylated. However, when treated 
with ATRA, Tert-/-S cells showed a much weaker increase in promoter methylation 
compared to Wt and Tert-/-R cells. In addition, once we re-plated cells in LIF-
containing media, after ATRA treatment, Tert-/-S cells showed a loss of cytosine 






Figure 36. (TOP) CpG methylation analysis of the Oct4 and Nanog promoters, by bisulphite 
sequencing, in Wt, Tert-/-S and Tert-/-R ESCs, during ATRA treatment followed by culture in LIF-
conditioned media. Each row represents CpGs in a sequenced clone. Full dots symbolize 
methylated CpGs, empty dots symbolize unmethylated CpGs, and grey dots indicate an 
uncertain methylation status or an undefined sequence. Percentage values indicate the 
proportion of methylated cytosines relative to total cytosine residues (n≥8). (Bottom) Map of 
DNA region amplified and sequenced by bisulphite sequencing. The red box indicates the position 
of primer annealing region (PAA) relative to the transcription starting site (TSS). 
 
To further confirm the importance of Dnmt down-regulation in the maintenance of 
differentiation of ESCs with critically short telomeres, we evaluated the ability Tert-/-
3b to suppress and maintain suppress pluripotency genes. We found that, although not 
completely, Dnmt3b expression rescued the ability of Tert-/- ESCs to differentiate as 
assessed by the ability to suppress Nanog, Oct4 and Sox2 during ATRA treatment 
(Fig. 37A, 37B, 37C) and to maintain differentiation (Fig. 37C).  
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Figure 37.  The response of Tert-/-3b ESCs to ATRA and subsequent LIF treatment A) (Left), 
Nanog immunofluorescence analysis (green = Nanog; Red = Actin). (Right), Nanog protein 
detection by western blot. Tub=β -tubulin. B) QRT-PCR analysis of pluripotency genes after 
ATRA-induced differentiation). (Wt, Tert-/-S and Tert-/-R same as in figure 25, samples analysed 
together). Gene expression at day 0 was arbitrarily set as 100 and the expression through the 
time course was normalized to mRNA levels at day 0. Values were expressed as a ratio to 
GAPDH. C) Single colony formation assay after ATRA treatment (6 days) and LIF-containing 
media (6 days) (n=3). (First 3 columns same as in figure 34, samples analysed together). A set of 
serial dilutions was performed and the percentage (n≥300) of viable ES cell colonies assessed 
with alkaline phosphatase assay. Error bar= SD. Wt= Wild type (parental ESC population); 
Tert-/-S = Tert deficient ESCs with short telomeres; Tert-/-R = Tert deficient ESCs with short 
telomeres, where Tert cDNA has been reintroduced. Tert-/-3b = Tert deficient ESCs with short 
telomeres ectopically expressing Dnmt3b.  
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This result suggested that both Nanog upregulation and reduced repressive ability of 
pluripotency genes upon ATRA treatment, and the ineffective ability to maintain 
differentiation of Tert null cells could be, at least in part, explained by impaired de 
novo methylation caused by downregulation of de novo Dnmt expression 
 
5.3 Nanog depletion in Tert-/- ESCs induces spontaneous 
differentiation and differentiation maintenance  
Finally, we decided to test whether we could bypass the impact of critically short 
telomeres and de novo Dnmts downregulation-induced impaired differentiation of 
Tert-/-S ESCs by depleting Nanog. We then transduced Tert-/-S cells with a lentiviral 
vector expression short hairpin RNA (shRNA) for Nanog. 
Nanog depletion (Fig. 38A, 38B) induced loss of ESC morphology and a decrease in 
pluripotency gene expression (38B, 38C). In addition, Tert-/-S cells transduced with 
shRNA targeting Nanog also exhibited in the ability to maintain differentiation 
(38D). These data implied that, although Tert-/-S ESCs presented both increase in 
some pluripotency genes and defect in differentiation, they were still responsive to 
alterations to the core pluripotency regulatory network.  
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Figure 38. Tert-/-S ESCs response to Nanog depletion. A) Nanog protein detection by western 
blot. Tub=β-tubulin. B) Relative gene expression in Wt, Tert-/-S, Tert-/-L, Tert-/-R, Tert-/-S shNanog, 
Tert-/-S shCtrl ESCs analysed by QRT-PCR. Data are represented as mean ± SD. ** = p<0.001. 
Background values (no reverse transcriptase added) were subtracted, and values were 
normalized to GAPDH (n>3). Statistical analysis was performed by ANOVA and related 
Dunnett’s test comparing every group with Wt values. C) Bright field images of Tert-/-S  ESCs 
transduced with shNanog and shCtrl. Micrograph bar indicates 200μm. D) Single colony 
formation assay after ATRA treatment (6 days) and LIF-containing media (6 days) (n=3). (First 
4 columns same as in figure 37, samples analysed together). A set of serial dilutions was 
performed and the percentage (n≥300) of viable ES cell colonies assessed with alkaline 
phosphatase assay. Error bar= SD. 
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5.4 Summary of chapter 5    
In this chapter we tested the impact of critically short telomeres in mouse ESCs and 
observed a delay in the kinetics of differentiation upon ATRA treatment. This delay 
was associated with a metastable differentiation state where Tert-/-S cells were able to 
re-express, under LIF stimulation, pluripotency genes suppressed under ATRA-
induced differentiation.  
 
We showed how this phenotype could be, at least partially, rescued by enforced 
expression of Dnmt3b, independent of telomere length. In this regard, we noticed 
how methylation of pluripotency gene promoters, under ATRA-induced 
differentiation was impaired in Tert-/-S cells. 
 
Finally, we demonstrated how this metastable differentiation phenotype could also 
be rescued independently of telomere length via Nanog depletion, thus underscoring 
the importance of this factor in maintaining Tert-/-S cells in an undifferentiated state 






Tert-/-S ESCs show differential 
response to p53 inhibition, and 




The results illustrated in chapter 3, 4 and 5 presented a picture where Tert-/-S ESCs 
exhibited a tendency to undergo dysregulation of pluripotency gene expression and 
impairment in achieving and maintaining differentiation. In this chapter, we show 
preliminary data indicating that ESCs possessing critically short telomeres may also 




6.1 Altered Nanog regulation in Tert-/-S cells upon inhibition 
of p53 transcriptional activity  
It is well known that uncapped telomeres lead to p53 activation (Chin et al., 1999). In 
addition, p53, which is highly abundant in mouse ESCs (Sabapathy et al., 1997), may 
serve an emerging, and controversial, role in regulation of self-renewal, pluripotency 
and iPS reprogramming (Abdelalim and Tooyama, 2012; Kawamura et al., 2009; Lee 
et al., 2010; Lin et al., 2005; Marion et al., 2009a). Despite the fact that the role of 
p53 role in the inhibition of reprogramming has been widely established (Kawamura 
et al., 2009; Marion et al., 2009a), its role in ESC self-renewal and differentiation is 
much less clear with studies attributing it both pro-differentiation (Lin et al., 2005; 
Qin et al., 2007) and anti-differentiation  activities (Abdelalim and Tooyama, 2012; 
Lee et al., 2010).  
We decided to assess Nanog and Oct4 expression on Wt and Tert-/-S ESCs upon 
treatment with pifithrin-α (PFT-α), a chemical inhibitor of p53 (Komarov et al., 
1999). Although Oct4 levels were unchanged after 16h of treatment, Wt and Tert-/-S 
cells showed an inverse regulation of Nanog expression (Fig. 39). 
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Figure 39. Relative gene expression in Wt, Tert-/-S and Tert-/-R ESCs treated with DMSO or 20µM 
of PTF-α analysed by QRT-PCR. Data are represented as mean ± SD. Background values (no 
reverse transcriptase added) were subtracted, and values were normalized to GAPDH N=2. 
 
6.2 Upregulation of insulin-pathway genes in Tert-/-S ESCs 
One of the characteristics of highly proliferative cells, included ESCs, is an increased 
ratio of anaerobic glycolysis over oxidative phosphorylation metabolism (Folmes et 
al., 2012). We then decided to investigate whether insulin –responsive genes were 
differentially regulated in Tert-/-S ESCs. We found that both insulin receptor (INSR) 
and insulin receptor substrate 2 (IRS2) mRNA were higher in Tert-/-S compared to Wt 
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and Tert-/-R cells (Fig. 40), suggesting that glucose metabolism might be altered in 
these cells.  
 
Figure 40. Relative gene expression in Wt, Tert-/-S and Tert-/-R ESCs analysed by QRT-PCR. Data 
are represented as mean ± SD. Background values (no reverse transcriptase added) were 
subtracted, and values were normalized to GAPDH N=2. 
 
Finally, we decided to analyse the levels of Lin28 in Wt and Tert-/-S cells. Lin28, a 
RNA-binding protein (Ambros and Horvitz, 1984), is not only important for iPS 
reprogramming and for maintaining pluripotency (Moss and Tang, 2003; Yu et al., 
2007), but it has also a role in glucose metabolism via its positive regulation of the 
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insulin-responsive genes INSR and IRS2 (through suppression of let-7 microRNA 
family, a Lin28 target) (Zhu et al., 2011). Quite surprisingly however, we found that 
Lin28 was downregulate in Tert-/-S compared to Wt and Tert-/-R cells (Fig. 41). This 
result indicates not only that Lin28 is the only pluripotency factor found 
downregulated in Tert-/-S compared to Wt, but also that the increase in the mRNA of 
insulin-pathway genes, in Tert-/-S cells, is independent of Lin28 overexpression. 
 
Figure 41. Relative gene expression in Wt, Tert-/-S, Tert-/-L, Tert-/-R ESCs analysed by QRT-PCR. 
Data are represented as mean ± SD. ** = p<0.001. Background values (no reverse transcriptase 
added) were subtracted, and values were normalized to GAPDH. N=5. 
 
6.3 Summary of chapter 6 
In this chapter, we tested the impact of critically short telomeres on other signalling 
networks known to influence cell pluripotency, and obtained preliminary evidence of  
the involvement of p53,in pluripotency gene dysregulation and, by inference, in 
impaired differentiation of Tert-/-S cells.  
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We also observed that Tert-/-S cells exhibit altered glucose metabolism. Surprisingly 
though, we found the Lin28, a hypothesized main candidate for increased insulin-
























Discussion and Perspectives 
7.1 Telomeres and epigenetic 
The connection between telomere length and chromatin compaction has been already 
established, at least at telomeric and subtelomeric regions, by the work of Maria 
Blasco and collaborators (Benetti et al., 2007). In this study, we uncovered a role of 
critically short telomeres in chromatin conformation both at telomeric and 
subtelomeric loci, and globally through the genome. In particular, we found that Tert-
/-S exhibited widespread cytosine hypomethylation compared to Wt and Tert-/-R 
ESCs. Furthermore, we also noticed, in Tert-/-S ESC, an increase of open chromatin 
marks acH4 and acH3K9 at subtelomeric regions as predicted by (Benetti et al., 
2007), and an overall increase, including a site-specific (e.g. Nanog promoter) 
displacement, of the repressive histone mark H3K27me3.  
PRC2 mediates trimethylation of H3K27, which, although dispensable for 
maintaining an undifferentiated and self-renewing state, characterises ESC identity 
(Shen et al., 2008). H3K27me3 is one of the main histone repression marks, and its 
reduction, in ESCs, on Nanog and Gata6 promoters has been connected to an 
increased expression of these genes (Lu et al., 2011; Shen et al., 2008; Villasante et 
al., 2011). Despite the overall increase of H3K27me3 in Tert-/-S ESCs, consistent 
with recent works that link H3K27me3 enrichment to unmethylated CpG contents 
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(Lynch et al., 2012; Mendenhall et al., 2010), its enrichment on the promoters of 
Nanog and Gata6 was diminished. These results are in keeping with the observation 
that CpG loss of methylation leads to a redistribution, and overall increase, of 
H3K27me3 on regions which are normally methylated, but a reduction of 
H3K27me3 on regions that are ordinarily unmethylated (Brinkman et al., 2012). Our 
results suggest a working model (Fig.42) whereby uncapped-telomere induced 
Dnmt3a and Dnmt3b downregulation results into subtelomeric and global DNA 
hypomethylation and displacement of H3K27me3 at gene promoters. Reduced 
H3K27me3 at gene control elements, in turn, affects the ability of the cell to repress 
pluripotency factors, which is a key step to achieve stable differentiation. 
 
 
Figure 42. Schematic model: telomere shortening impairs expression of Dnmt3 isoforms, leading 
to genome-wide DNA hypomethylation, which in turn affects H3K27me3 enrichment on specific 
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loci (e.g. Nanog), thus impairing the ability to sustain pluripotency factor repression after 
differentiation and growth re-stimulation.  
 
Notably, due to the impossibility, for unclear reasons, to generate Tert-/- embryos 
from our Tert+/- mice (Liu et al., 2000), and lack of time to perform Tert gene 
targeting on early passage ESCs, we had to use previously generated Tert-/- ESCs 
(Liu et al., 2000). This approach has many disadvantages compared to using new ex-
vivo isolated ESCs. First of all, it implies that, in order to generate short telomere 
Tert-/- ESCs, we had to maintain Tert-/- ESCs in culture for many passages (70 or 
more passages). The extended growth of cells in culture may lead to accumulation of 
DNA mutations, or to a selection of cells with a higher preference to grow in culture 
than to differentiate. However, the observation of similar defects in differentiation in 
two independently generated Tert-/- ESCs (Liu et al., 2000) compared to parental 
ESCs, and the rescue phenotype after reintroduction of Tert in late passages Tert-/- 
ESCs rather suggested a telomere-based effect.  Nevertheless we cannot completely 
exclude the possibility that secondary mutation(s) accumulated, over passages, in 
Tert-/-S ESCs and played a role in the described effects.  
In any case, assuming the observed effects are indeed due to a telomere shortening, 
many questions still remain to be addressed: What is the molecular link between 
critically short telomeres and de novo Dnmts downregulation? Can these data 
suggest a different way to look at (some) kinds of tumours? What is the connection 
among short telomeres, downregulation of Lin28 and altered glucose metabolism?  
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7.2 De novo Dnmt downregulation and uncapped-telomere 
caused inhibition of differentiation activity (UCCIA) 
In chapters 4 and 5, we showed that Tert-/-S ESCs exhibit a reduced expression of de 
novo Dnmts compared to Wt and Tert-/-R ESCs, and demonstrated that this 
downregulation led to improper pluripotency promoter methylation and unstable 
differentiation. We also showed that enforced expression of Dnmt3b was able to 
almost completely rescue proper differentiation in Tert-/-S cells, independently of 
telomere length. Lack of complete rescue could be due to fact that Dnmt3b was 
reintroduced, but not Dnmt3a (which was also found downregulated in Tert-/-S) and 
Dnmt3L (whose expression levels were not tested).  
The concept that reduced de novo methylation may lead to a metastable state of 
differentiation is not, per se, surprising, having been already established in the 
literature (Feldman et al., 2006; Jackson et al., 2004; Sinkkonen et al., 2008). What 
we found unexpected and fascinating was that critically short telomeres could trigger 
this mechanism. However, a few points should be considered regarding the apparent 
reversibility into ESCs of Tert-/-S cells which lost the expression of pluripotency 
markers. First, simply taking the loss of expression of pluripotency genes as the sole 
indicator of differentiation, without monitoring the appearance of differentiation 
markers, may hide a situation where some Tert-/-S cells strongly reduce, but do not 
suppress, the expression of pluripotency genes under ATRA treatment and re-express 
them after re-introduction of LIF into the culture medium. Second, even if the loss of 
expression of pluripotency factors, such as Oct4, was a sufficient indicator of 
differentiation, it would not be possible to exclude that a small percentage of Tert-/-S 
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cells, resistant to differentiation, persisted in the population of properly differentiated 
cells and expanded after re-addition of LIF into the culture medium. 
Nevertheless, whether Tert-/-S cells undergo a full (from completely differentiated 
cells) or partial (from incompletely differentiated cells) de-differentiation event or 
whether a sub-population of cells insensitive to differentiation clues can expand, it 
remains to be determined how telomere shortening affects Dnmt expression. A 
possible hypothesis could be that this uncapped-telomere caused inhibition of 
differentiation activity (UCCIA) is triggered by a DNA damage response originating 
from unprotected telomeres. We have, in fact, already seen in chapter 6 how the 
inhibition of p53 in Tert-/-S ESCs can restore Nanog expression to levels closer to Wt 
ESCs. So, it would be interesting to test whether inhibiting a telomere-dependent 
DNA damage response could rescue Dnmt expression. However, it should be noticed 
that Nanog downregulation in Tert-/-S treated with PFT-α is hardly due to a putative 
effect on Dnmt expression. In fact, even in the presence of a rescue of Dnmt 
expression, an incubation of 16h would have not been sufficient to restore genomic 
DNA methylation. This result suggests that dysregulation of pluripotency genes in 
Tert-/-S may be due to more than one mechanism (Fig. 43A, 43B).  
Another hypothesis, which should be tested, is whether UCCIA may be caused by 
genomic mislocalization of telomeric factors such as Rap1 or Rif1 following 
telomere shortening (Fig. 43C).  
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Figure 43. Schematic representation of putative models connecting telomere shortening to de 
novo Dnmt downregulation and UCCIA. A) Uncapped telomeres trigger a DNA damage 
response, which mediates de novo Dnmt downregulation. B) Uncapped telomeres trigger DNA 
damage response and/or unknown mechanisms to downregulate Dnmts. In parallel DNA 
damage response may have Dnmt-independent effects upon UCCIA. C) Telomere shortening 
leads to misplacement of telomeric factors involved in gene regulation and pluripotency 
maintenance, with subsequent induction of UCCIA. 
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7.3 Necessity to examine some cancer therapies from a 
different angle? 
Cancer cells are highly proliferative and they require an appropriate maintenance of 
telomere length to safeguard their replicative potential. In approximately 85% of 
cases telomeres are preserved by re-activation of telomerase (Matsuo et al., 2009). 
When telomerase is inhibited or deleted in culture, telomerase-positive cancer cells 
shorten their telomeres with each cell division and eventually enter senescence 
(Hahn et al., 1999; Taboski et al., 2012; Zhang et al., 1999). In the other 15% of 
cases, instead, cancer cell telomeres undergo ALT-mechanisms (Cesare and Reddel, 
2010).  Thus, an obvious rationale is to target the inhibition of telomerase and/or 
telomere maintenance as a putative cancer therapy (Biffi et al., 2013; Folini et al., 
2011; Roth et al., 2010). 
 
The regulation of many factors involved in pluripotency and differentiation has not 
only effects on physiological development, but is also important in human disease. 
For example, it is known that some pluripotency factors (e.g. Nanog, Oct4) tend to 
be highly abundant in undifferentiated cancer cells and putative cancer stem cells 
(Tysnes, 2010). Furthermore, treatment of some kind of tumours (e.g. promyelocytic 
leukemia) requires the usage of pro-differentiating chemicals such as retinoic acid. 
(Petrie et al., 2009).  
 
A question that rises spontaneously is whether critically short telomeres affect the 
response of cancer cells to pro-differentiating agents, and in this case whether a 
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telomere/telomerase targeting strategy may have, in such a situation, the undesirable 
effect to impede cell differentiation. Speculating further, one may propose that, in 
particular cases of undifferentiated tumours, a telomere-elongation approach, in 
combination with other treatments, could improve the response to the therapy (Fig. 
44). In support of this hypothesis, it is worth mentioning a very recent work from 
Hiroyuki Seimiya and colleagues, which have shown how lengthening telomeres of 
human prostatic cancer cells with short telomeres led to differentiation of tumour 
cells (Hirashima et al., 2013).   
 
Figure 44. Schematic representation of speculative impact of contrasting telomere shortening in 
particular cases of cancer therapy. 
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7.4 Affecting glucose uptake 
Tert-/-S ESCs appear to have higher levels of mRNA of the insulin-pathway genes 
INSR and IRS2 compared to Wt ESCs, suggesting that these cells might have 
enhanced glucose uptake and glycolysis. This result itself may not be surprising, 
considering that ESCs have an increased anaerobic over aerobic metabolism ratio 
compared to differentiated cells (Folmes et al., 2012), and that Tert-/-S showed an 
overall increase in pluripotency and self-renewing genes compared to Wt and Tert-/-R 
ESCs. In fact the increase in IRS2 and INSR could simply reflect the upregulation of 
pluripotency genes such as Nanog and Essrb in Tert-/-S cells. However, the fact that 
Lin28, one of the main positive regulators of insulin-pathway genes (Zhu et al., 
2011), has been found as the only pluripotency factor that is repressed in Tert-/-S, 
(among those tested), is somewhat puzzling. In addition, both Lin28 downregulation 
and telomere shortening have been connected, separately, to Diabetes mellitus 
type 2, a disease characterised by insulin resistance (Guo et al., 2011; Zhu et al., 
2011). 
Our data demonstrate a decrease in Lin28 expression in ESCs with critically short 
telomeres, and thus may offer a possible molecular link between the two phenotypes. 
In Tert-/-S cells, insulin-pathway genes could be upregulated, regardless of Lin28 
downregulation, due to the overexpression of other pluripotency genes. It would be 
very interesting to assess whether, in differentiated cells with critically short 
telomeres, Lin28 and insulin pathway genes are downregulated, and whether 
telomere elongation can rescue their expression (Fig. 45). 
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Figure 45. Schematic representation of hypothetical mechanism of insulin pathway gene control. 
Tert-/-S ESCs show increase in insulin pathway genes, despite reduced Lin28, perhaps as a 
response to an overall increase in pluripotency gene expression. In differentiated cells, short 
telomeres lead to Lin28 downregulation and subsequent repression of insulin pathway genes.  
  
7.5 Final remarks 
The results presented in this work provided conceptual advances in the field of 
telomere biology and its effects on chromatin and gene expression, and in the field of 
pluripotency maintenance in ESCs. Having found that critically short telomeres 
affect chromatin compaction even at a global genomic level, this work completes a 
picture initiated by other studies (Benetti et al., 2007), which observed telomere-
shortening effects on chromatin only at regions proximal to telomeres.  
 103 
As for the discovery of uncapped telomeres impacting on pluripotency gene 
regulation, this study provides us with new information about the complex network 
of factors and mechanisms necessary to regulate the pluripotent state of embryonic 
stem cells. 
Finally, our discovery of the role of critically short telomeres in regulating the 
kinetics and stability of ESC differentiation opens new perspectives on the functions 
of telomeres in the cell.  
The fact that telomere regulation seems to be a sophisticated process, which not only 
provides the cell with replicative potential, but that also affects cell fate decisions is 
intriguing, and clearly demands further studies to investigate its role in different 
contexts (e.g. progenitor cells, cancer cells, etc.) in order to gain a complete picture 
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Figure S1 (related to Fig. 1). Characterization of telomerase activity, telomere 
length, cell cycle profile, morphology and pluripotency gene expression in Tert-/- 
ESCs. A) Telomere repeat assay protocol (TRAP) performed on protein extracts (the 
equivalent of 5 x 104 cells) from Wt ESCs (lanes 1, 2), Tert-/-R ESCs (3 independent 
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rescued clones; lanes 1, 2, 5, 6) untreated or after digestion with ribonuclease A (RN) 
and Tert-/-S ESCs (lane 7) (cells at between 67 and 74 passages); IC = internal PCR 
control. B) Q-FISH analysis of indicated genotypes; statistical significance was 
analyzed by Welch’s unpaired t-test; L = long telomeres (passage 30); S = short 
telomeres (passage 70); R = Tert-/-S cells after reintroduction of Tert (passage 74, 
including 4 passages under hygromycin selection). The difference in the incidence of 
signal-free ends relative to total ends between Tert-/-S (49/417) and Tert-/-L (14/416) 
or Tert-/-R (4/417) was statistically significant (p<0.00001 for each comparison, 
Fisher's exact test). N = number of chromosome ends; y-axis, number of events; x-
axis, telomere signal intensity in arbitrary units.  C) Average of mean telomere signal 
intensity relative to Wt. Data are represented as mean ± SD (n=3); Number of 
chromosomes per sample ≥ 350 D) Cell cycle profile of Wt and Tert-/-S cells.  E) 
Bright field image of the same samples as in (D), Micrograph bars indicate 200µm. 
F) Oct 4 and Nanog protein detection by western blot. β-Tubulin was used as an 
internal control (Tub). L = long telomeres (passage 70); S = short telomeres (passage 
30); n=3 for Oct4 blot,  n=10  for Nanog blot. G) Immunofluorescence analysis of 
Nanog expression in ESCs. Micrograph bar indicates 15µm. H) Detection of 
H3K27me3 and histone H3 (as a control) by western blot (n=3).  I) ChIP analysis of 
Nanog occupancy on Nanog and Gata6 promoters (see Supplementary Experimental 
Procedures for details). A murine IgG antibody was used as a negative control. Data 
are represented as mean ± SD (n=3). * = p<0.05; *** = p<0.0001. J) 3D-FISH 
analysis of chromatin (top) and telomere DNA distribution (bottom) in ESC nuclei 
(n=3).  The nuclear area has been divided in 5 equal concentric zones, where 1 is the 
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inner and 5 the most peripheral zone. Y-axis indicates the percentage of signal in 





Figure S2 (related to Fig. 2). Analysis of Nanog, Sox2, and Oct4 expression in 
response to all-trans retinoic acid and LIF.  A) Pluripotency factor expression in 
Tert-/- ESC with long telomeres (Tert-/-L). (Left) Detection of Nanog and β-tubulin by 
western blot (n=3); (Right) QRT-PCR analysis of pluripotency genes after ATRA-
induced differentiation and LIF re-addition. Gene expression at day 0 was arbitrarily 
set as 100 and the expression through the time course was normalized to mRNA 
levels at day 0. Sample nomenclature as indicated in Figure 1. C) QRT-PCR analysis 
of pluripotency genes after ATRA-induced differentiation and LIF re-addition. Gene 
expression at day 0 was arbitrarily set as 100 and the expression through the time 




Figure S3 (related to Fig. 3). Nanog immunofluorescence analysis after ectopic 
expression of Dnmt3b in Tert null ESCs with short telomeres. Cells were analyzed 
for Nanog via immunofluorescence at d0, day 0; d6 ATRA, 6 days of treatment with 
ATRA; d6 LIF, a further 6 days after removal of ATRA and re-addition of LIF-
conditioned media. Note that the top nine panels are identical to Figure 2B, but are 
reproduced here because all samples were analyzed contemporaneously (n= 3). 
Micrograph bars indicate 15µm (n= 3).  
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Figure S4 (related to Fig. 4). Knockdown of Nanog in Tert null cells A) Bright 
field image of shNanog and shControl transduced Tert null cells. B) Nanog protein 
detection by western blot. Tub= β-tubulin (n=3). C) Relative gene expression of 
shNanog and shControl transduced cells analyzed by QRT-PCR, normalized over 
GAPDH (n=3). Data are represented as mean ± SD. * = p<0.05; ** = p<0.01
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ChiP Fw Rv 
GAPDHF 5’-AAGCTCATGAGGCACAGAATGGT C-3’ 5’TGGGTACATGGTGACTTTCCTAGG C-
3’ 
Gata6F 5’-TGACCCAGGAGGGGGCGAGT-3’ 5’-CCGCCACCCAGGGCAGAAGA-3’ 
NanogF 5’-ACTCCAAGGCTAGCGATTCA-3’ 5’-AATAGGGAGGAGGGCGTCTA-3’ 
Oct4D  5’-CTGTAAGGACAGGCCGAGAG-3’ 5’-CAGGAGGCCTTCATTTTCAA-3’ 
QRT-PCR  Fw Rv 
Cdx2I 5’-CCTGCGACATTGTTTAG-3’ 5’-TCCCGACTTCCCTTCACCATAC-3’ 
Dnmt1 5’-TGGGCTGATGCAGGAGAAAAT-3’ 5’-GCGCTTCATGGCATTCTCCTT-3’ 
Dnmt3a2Si 5’-AGGGGCTGCACCTGGCCTT-3’ 5’-TCCCCCACACCAGCTCTCC-3’ 
Dnmt3bSi 5’-TGGGATCGAGGGCCTCAAAC-3’ 5’-TTCCACAGGACAAACAGCGG-3’ 
EsrrbI 5’-CAGGCAAGGATGACAGACG-3’ 5’-GAGACAGCACGAAGGACTGC-3’ 
GAPDHF 5’-CCATCACCATCTTCCAGG-3’ 5’-CCTGCTTCACCACCTTCTTG-3’ 
Gata4F 5’-CTGTCATCTCACTATGGGCA-3’ 5’-CCAAGTCCGAGCAGGAATTT-3’ 
Gata6F 5’-TTGCTCCGGTAACAGCAGTG-3’ 5’-GTGGTCGCTTGTGTAGAAGGA-3’ 
Klf4T 5’-AGTGTGACAGGGCCTTTCCAGGT-3’ 5’-AAGCTGACTTGCTGGGAACTTGAC 
C-3’ 
NanogF 5’-AGGGTCTGCTACTGAGATGCTCT  G-3’ 5’-CAACCACTGGTTTTTCTGCCACC  G-
3’ 









Sox2T 5’-TAGAGCTAGACTCCGGGCGATG   A-3’ 5’-TTGCCTTAAACAAGACCACGAA   A-
3’ 
Tbx3F 5’-TCTCCATCGTGGGGACAT-3’ 5’-TTGTCGCGGCCTGGCTCCTCG-3’ 
Zfp281F 5’-TGAGCCCAGGCACCCA-3’ 5’-TGGAGAGGTGAAGACAAGCTGA  C-
3’ 





Oct4S ’-AGGATTTTGAA GTTGAAAATGAA GG-
3’ 
’- TC CCAATCC C C-3’ 
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Table S1 (related to Fig. 1).  List of oligos employed in this study. Superscripts 
indicate first author initial (Dahl et al., 2010; Fidalgo et al., 2011; Ivanova et al., 
2006; Sinkkonen et al., 2008; Takahashi and Yamanaka, 2006). Fw, forward primer; 
Rv, reverse primer.  
 
Supplemental Experimental Procedures: 
Telomerase activity assay. The telomere repeat amplification protocol, TRAP, was 
conducted with the TRAPeze Telomerase Detection Kit, Chemicon International, 
according to manufacturer’s instructions. 
Plasmid construction. The plasmid pTRE-Bi-Tert-IRES-EGFP-Hygro was 
constructed by amplification of Tert cDNA by PCR and cloning it into pTRE-Tight-
Bi (Clontech) following digestion with EcoRI and SalI. IRES-EGFP sequence was 
obtained from pCAGMKOSiE (from K.Kaji) and inserted into pTRE-Tight-Bi 
(following digestion with SalI and EcorV) using SalI and HpaI sites and then 
inserted into pTRE-Bi-Tert using NotI sites. Finally, the hygromycin-resistance gene 
was cloned by PCR into the XbaI restriction site of pTRE-Tight-Bi and pTRE-Bi-
Tert-IRES-EGFP vectors to create pTRE-Bi-EGFP-Hygro and pTRE-Bi-Tert-IRES-
EGFP-Hygro. The pCAG-rtTA-advanced vector was constructed by removal of the 
MKOS ORFs from CAGMKOSiE with EcoRI and BamHI and replacement with the 
advanced tetracycline reverse transactivator sequence (Clontech). The plasmid 
pCAG-Dnmt3b-IRES-puromycin vector was constructed by removal of the MKOS 
ORFs from CAGMKOSiE with EcoRI. Dnmt3b was subcloned from a Dnmt3b 
expression vector (Thermo scientific) and inserted pCAG-IRES-EGFP following 
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digestion EcoRI and SalI. IRES-EGFP was replaced with IRES-Puro (from 
pIRESPuro2, Clontech) after digestion with PmlI and PvuII. 
Fluorescence-activated cell sorting (FACS). Hoechst stain (5µg/ml) was added to 
the cell culture and incubated for 30 minutes. Cells were harvested and resuspended 
in 0.5 ml of 1X PBS and analyzed for cell cycle distribution using a Becton 
Dickinson Fluorescence Activated Cell Sorter. After gating on the appropriate 
channels, the percentage of cells in G1, S, or G2/M were calculated. For FACS 
analysis of Nanog expression, cells were fixed and stained as indicated (Festuccia 
and Chambers, 2011).  Cell sorting after transduction with Oct4-GFP was carried out 
as described in Zheng and Hu, 2012. 
Protein extraction and western blot analysis. Histones were acid-extracted as 
follows: Cells were harvested and washed twice with ice cold 1X PBS. Cells were 
resuspended (107 cells/ml) in TEB buffer (PBS 1X, 0.5% v/v Triton X-100, 2 mM 
PMSF, 0.02% v/v NaN3) and left on ice for 10 minutes with gentle stirring to 
enhance lysis. Cells were spun at 800 xg for 10 minutes at 4°C, washed in TEB 
buffer, and pelleted as above. Cells were resuspended in 0.2 N HCl (4 x107 cells/ml) 
and incubated overnight at 4°C. Cells were pelleted as above, and the supernatant 
was recovered and stored at -80°C. Protein extracts were resolved on 15% w/v SDS-
PAGE, transferred to nitrocellulose and blocked overnight with 3% w/v BSA in 1X 
PBS. Rabbit anti-histone H3 (Abcam) and mouse anti H3K27me3 (Abcam) were 
used as primary antibodies. 
For non-histone protein extraction, cells were lysed for 30 minutes on ice in RIPA 
buffer (50 mM Tris-HCl pH 7.4, 1% v/v NP-40, 0.25% w/v Na-deoxycholate, 150 
mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 µg/ml each of aprotinin, leupeptin and 
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pepstatin, 1 mM Na3VO4, 1 mM NaF). Cells were pelleted at 20,800 xg for 10 min at 
at 4°C. The supernatant was recovered and stored at -80°C. Protein extracts were 
resolved on 10% w/v SDS PAGE, transferred to nitrocellulose and blocked overnight 
with 5% w/v non-fat dry milk in 1X PBS. Rabbit anti-Nanog (Bethyl labs), anti-
Dnmt3b (Abcam) and Dnmt1 (Abcam), goat anti-Oct4 (Santa Cruz) and mouse anti- 
β-Tubulin (Sigma) were used as primary antibodies. Anti mouse and anti rabbit 
peroxidase-conjugated were used as secondary antibodies followed by detection with 
ECL Plus luminescent reagent (Amersham Biosciences) or with LI-COR in which 
instance the secondary antibodies employed were donkey anti-rabbit IRDye 800CW 
(green) and donkey anti-mouse IRDye680 (red) (Odyssey). All experiments were 
repeated at least three times. 
Immunofluorescence. Cells were fixed in 4% v/v paraformaldehyde (PFA)/PBS 
according to manufacturer’s instructions (Abcam). Rabbit anti-Nanog (Bethyl labs) 
and Alexa fluor® Goat anti-rabbit-488 were used as primary and secondary 
antibodies. Rhodamine-phalloidin (Sigma) was used to detect actin. DNA was 
stained with DAPI. ImageJ software was employed to define the relative 
fluorescence intensities of single cells (for channels 488), with DAPI fluorescence as 
internal control. Individual values were used for quantitative analysis of Nanog 
expression levels among genotypes as described (Savarese et al., 2009). Statistical 
analysis was performed using Welch’s unpaired t-test.   
3D Analysis of Cell Nuclei. Cells were fixed in in 4% v/v paraformaldehyde 
(PFA)/PBS for 15 min, then treated as described for Q-FISH analysis of telomere 
fluorescence. At least 25 interphase nuclei were analyzed for Wt, Tert-/-S and Tert-/-L. 
Images were acquired using a Nikon TE-2000 microscope equipped with a 1.45 
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numerical aperture 100× objective, PIFOC Z-axis focus drive (Physik Instruments), 
Sedat quad filter set, and CoolSnapHQ High Speed Monochrome charge-coupled 
device camera (Photometrics). Images were deconvolved from 0.2-µm sections using 
AutoquantX. 
Deconvolved images were analyzed for chromosome and telomere distribution using 
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Main contributions to the work: A) Performed Q-FISH experiments (as described in 
material and methods). B) Introduction, and selection for positive colonies, of mouse 
Tert cDNA into Tert-/- ESCs (as described in material and methods). 
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